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ABSTRACT 
William A. Black: Development and Application of Microfluidic Capillary Electrophoresis-
Electrospray Ionization Devices for the Analysis of Biological Samples  
(Under the direction of J.M. Ramsey) 
 
The development and optimization of tools and techniques that characterize 
biological systems on the molecular level are necessary, and can provide significant benefits 
to society. Capillary electrophoresis (CE) has many advantages when analyzing biological 
samples, including low sample volume requirements, fast analysis times, and high separation 
efficiencies. Performing the CE separation on a microfluidic device can yield improvements 
due to integration of multiple functional components, automation, and efficient heat 
dissipation. The work describes the development of microchip capillary electrophoresis-
electrospray ionization (CE-ESI) devices for various applications focused on the analysis of 
biological samples. First, microchip CE-ESI was coupled with commercial liquid 
chromatography (LC) to perform a multi-dimensional separation. A tryptic protein digest mix 
was utilized to probe the separation performance of the LC-CE-ESI system. In 50 minutes, a 
peak capacity of 1500 was observed. The technique was also used to characterize the 
glycopeptides of a monoclonal antibody. Increasing the mass spectrometer acquisition speed 
resulting in improved sampling in both the CE and LC dimensions. Microchip CE-ESI was 
also investigated for use in hydrogen deuterium exchange mass spectrometry (HX MS). A 
state of the art commercial LC system was compared to microchip CE-ESI for both 
separation and deuterium uptake/recovery performance. The microchip CE-ESI method 
! iv!
proved to be much faster than the LC counterpart with improved separation performance. For 
the CE-MS method, a peak capacity of 62 was observed in a 1 minute separation, compared 
to a 4 minute LC-MS separation with a peak capacity of 31. Overall, the deuterium uptake 
and recovery between the two methods were similar. Sequence coverage and peptide 
redundancy scores for the CE-MS method were lower compared to the LC-MS, due to the 
narrow duration of the CE-MS peaks, lower sensitivity of the mass spectrometer used, and a 
much smaller injection volume. Future improvements to the mass spectrometer as well as 
integrating sample processing with the CE-ESI microchip will likely improve these metrics. 
Next, microchip CE-ESI at low temperatures was investigated. A Peltier device was used to 
cool the microchip; temperatures between 30 °C and 0 °C were investigated. At lower 
temperatures, a linear increase in theoretical plates was observed, as was an increase in 
analyte migration time. Furthermore, lowering the temperature of the separation decreased 
deuterium back exchange, indicating the potential of low temperature microchip CE-ESI for 
HX MS experiments. Finally, integrated sample processing was investigated by coupling a 
solid phase extraction (SPE) bed on a CE-ESI microchip. Injection broadening incurred 
during the transfer of analyte from the SPE bed to the CE separation channel resulted in a 
decrease in the separation performance. Utilizing transient isotachophoresis (tITP) focusing 
following the transfer improved the separation performance of the SPE-CE-ESI method and 
maintained the pre-concentration values. For a four peptide mix, enrichment values of 
between 70 and 2500 were observed. The method was applied to a phosphorylase B tryptic 
digest. A peak capacity of 147 was observed for a 5 minute separation. Over two orders of 
magnitude of pre-concentration was observed with a simultaneous increase in peak capacity. 
However, the number of observed peptides in the electropherogram decreased from 150 to 97. 
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Overall, the work described in this thesis illustrates the potential of microchip CE-ESI for the 
analysis of biological samples, demonstrating high separation efficiencies, fast analysis times, 
and integration with other functional elements. 
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CHAPTER 1: INTRODUCTION 
1.1 Importance of Biological Analysis 
A clear and thorough understanding of biological processes is a critical goal for 
countless applications, ranging from medicine, food science, water purification, and 
industrial biotechnology. Exploring the processes involved with these applications can have a 
significant impact not just on the science field, but also on society as a whole. Genetically 
modified organisms (GMO) present a salient example of this. It’s estimated that the world’s 
population will increase to over 9 billion individuals by 2050, which presents an immense 
agricultural challenge to provide sufficient levels of food.1 GMO can potentially increase 
crop yield, improve pest resistance, increase nutritional content, and reduce the resources 
required.2 However, investigation and characterization of the involved biological systems is 
required in order to produce these organisms with the desired traits. The prevalence of cancer 
in the United States represents another example of how investigating biological processes can 
potentially benefit society. The American Chemical Society estimates that over 585,000 
individuals in the U.S. died of cancer in 2014.3 Furthermore, it’s estimated that the annual 
direct medical cost of cancer in the U.S. is over $124.5 billion.4 An enhanced grasp of the 
underlying biological processes involved would likely result in improvements to the 
prevention, diagnosis, and treatment of these diseases and reduce the burden of cancer on 
society.  
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To facilitate a deeper understanding of these biological processes, it’s necessary to 
comprehend the mechanisms and pathways and their constituents on a molecular level. In 
order to perform these investigations, analytical techniques that can probe these molecules, 
such as proteins, peptides, carbohydrates, small molecules, and nucleic acids are needed. 
Methods to characterize these molecules and their interactions have been the focus of the 
scientific community for decades. Countless techniques and instruments have been 
developed and great strides have been made in numerous fields since the mid 19th century. 
However, further improvements are necessary to realize the lofty goal of fully understanding 
biological systems and translating that knowledge to the macro environment. Advancements 
in the technology used to study biological processes will likely result in impactful gains to 
numerous biomedical, agricultural, and industrial applications and yield tangible benefits to 
society. 
1.2 Electrophoresis  
 Since the initial descriptions of blood serum protein separations in 1937 by Tiselius,5-
9 electrophoresis has been an invaluable tool for the analysis of biological samples.10,11 
Electrophoresis is defined as the movement of a charged species in a fluid or gel under the 
influence of an electric field. Equation 1 describes the electrophoretic velocity (v) of an 
analyte, where µ corresponds to the electrophoretic mobility of that analyte and E 
corresponds to the applied electric field.12 
v = µE        (1) 
 Equation 2 approximates the electrophoretic mobility of a charged particle, where q is 
the charge on the particle, η is the viscosity, and r is the Stokes’ radius of the species.  
! 3!
                                                                       
µ= q6πηr      (2) 
 As illustrated by Equation 2, electrophoresis separates analytes primarily based on the 
molecule’s charge-to-size ratio. For analytes that have the same charge-to-size ratio, such as 
DNA, the addition of a sieving medium, such as cross-linked polyacrylamide, results in a 
size based separation.10 In the nearly 80 years since the seminal publications, many different 
forms of electrophoresis have been applied to a wide variety of applications, including but 
not limited to polyacrylamide gel electrophoresis (PAGE),13,14 agarose gel 
electrophoresis,15,16 free flow electrophoresis,17,18 isoelectric focusing (IEF),19,20 and 
isotachophoresis.21,22 Two dimensional denaturing PAGE (2D PAGE) in particular, the 
coupling of IEF in the first dimension and PAGE in the second dimension, has become an 
extremely powerful technique for the analysis of intact proteins. To date, more than 10,000 
protein spots can be resolved by a single gel, which are typically 15 x 20 cm in size.10 
However, the technique is not without disadvantages. Despite the impressive resolving power 
and decade of routine use, 2D PAGE is time consuming, labor intensive, only semi-
quantitative, has limited detection methods, and has historically not performed well with low 
abundance or hydrophobic proteins.14  
1.3 Capillary Electrophoresis 
Prior to the early 1980’s, electrophoretic methods as they were commonly operated, 
although widespread, were not instrumental methods of analysis on par with column 
chromatography. A majority of the electrophoretic methods employed required the use of 
stabilizing media such as gels, which made difficult the adoption of on-line sample 
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application, detection, quantification, and automated operation.23 Stabilizing media were 
required to suppress the convective flow that arose from the application of voltage to the 
electrophoretic system. The passage of an electric field yields the generation of heat. As heat 
is generated across the entire electrophoretic system but only removed at the edges, a radial 
heat gradient forms, resulting in the unwanted spreading of analyte bands.23,24 The heat 
gradient causes analyte zone broadening in multiple ways. First, the higher temperature fluid 
in the center of the system will be less dense than the cooler fluid at the edges, resulting in 
convective current. Second, the higher temperature fluid will also be less viscous, resulting in 
increased analyte mobility.23,24 The use of stabilizing media reduced the convective flow 
observed but does not address the generation of the heat gradient. Furthermore, the 
stabilizing media also added to broadening of the analyte zones through eddy migration.23,24 
Therefore, the removal of the stabilizing gel from the electrophoretic system would have 
many advantages, including easier adoption of an instrumental method, which could 
automate many functions, as well as reduced zone broadening, increasing separation 
performance.   
 With the introduction of capillary zone electrophoresis (CE) in 1981,24 Jorgenson et 
al. demonstrated an instrumental electrophoretic technique with very high resolving power 
and without the requirement of stabilizing media. CE operates to separate analyte zones by 
applying an electric field across an open tubular capillary with a narrow diameter. The 
narrow diameter of the capillary has many benefits. First, in the absence of a stabilizing 
media, the capillary walls themselves will exert a stabilizing anti-convective force, known as 
the wall effect.25 Without the stabilizing media, eddy migration is eliminated, reducing zone 
broadening. Second, the smaller tube diameter improves heat transfer and acts to reduce the 
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generation of the radial thermal gradient. While thermal gradients in the capillary cannot be 
eliminated entirely, the narrow tube diameter helps to reduce the influence of the thermal 
gradient on zone broadening through ‘averaging’ of the analytes’ radial position throughout 
the separation. A thermal gradient only imparts zone broadening if molecules spend an 
extended period of time in either the hot or cool radial region of the capillary. By decreasing 
the radius of the capillary, analytes can diffuse across the entire radial dimension of the 
capillary on the time scale of the separation, reducing the effect of the temperature gradient 
broadening.23,24 The culmination of these effects to reduce broadening result in a technique 
capable of producing very high separation efficiencies. Equation 324 illustrates the number of 
theoretical plates (N) for a CE separation, where V is the applied voltage, D is the diffusion 
coefficient, and µ is the electrophoretic mobility. Equation 424 illustrates the required 
migration time (t) for an analyte, where L is the capillary length. 
     N =
µV
2D       (3) 
       
t = L
2
µV        (4) 
 As illustrated by Equations 3 and 4, the number of theoretical plates for a CE 
separation is primary controlled by the applied voltage. The length of the separation capillary 
has no bearing on the observed efficiency, but is very influential on the overall time of the 
separation. Therefore, the best results would be predicted with the application of high applied 
voltages in short capillaries. To date, CE is known as a separations technique with many 
advantages including high speed, high efficiency values, low sample requirements,26 and a 
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wide analysis scope as CE has been applied to nearly every biological sample imaginable 
including nucleic acids,27,28 amino acids,29,30 peptides,31,32 proteins,33,34 organelles,35,36 
viruses,37,38 and whole cells.39,40 Most of the early work focused on CE analysis utilized 
optical detection methods, such as UV absorbance of fluorescence detection. While UV 
absorbance detection is widely applicable to many different analytes, the sensitivity of the 
method is a concern. Fluorescence detection is quite sensitive, but only certain analyte are 
naturally fluorescent, and labeling the analytes with a fluorescent tag can have a negative 
effect on the analysis of the analytes of interest. Furthermore, optical detection methods do 
not provide any mass or structural identification data. As the scope of analysis grew for many 
applications and sample complexity increased, detection methods that provided additional 
structural identification, sensitivity, and universal application were desired.41  
1.4 Capillary Electrophoresis– Mass Spectrometry  
Mass spectrometry (MS) is an extremely powerful technique that provides a wealth of 
chemical and structural information. However, prior to the advent of electrospray ionization 
(ESI)42-44 and matrix assisted laser desorption/ionization (MALDI),45 MS detection was not 
widely applicable to nonvolatile biological species.46,47 The development of these techniques 
greatly expanded the scope of biological analysis and has proven to be very valuable for the 
investigation of biological systems. In addition to providing molecular mass information with 
a high degree of accuracy, MS detection is sensitive, has a wide dynamic range, provides 
structural information, and can detect non-covalent complexes.48 Furthermore, the coupling 
of ESI with liquid phase separations techniques makes it especially attractive for studying 
biological analytes.  
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ESI is produced by passing a fluid through a capillary tube and applying a potential 
between the capillary and the counter electrode, usually the inlet of the mass spectrometer. 
The distance between the ESI emitter and the inlet is kept small, around 0.5 to 2 cm.49 The 
combination of the fluid flux out of the capillary with the potential at the outlet results in the 
generation of a Taylor cone, where small charged droplets of analyte are transported into the 
inlet of the mass spectrometer. As the droplets transverse the distance between the emitter 
and the inlet, desolvation occurs, yielding transformation of analytes in the liquid phase to 
gas phase ions capable of analysis by mass spectrometry. Through the desolvation process, 
the droplets shrink in size as the solvent evaporates; however, the charge of the droplet 
remains similar, resulting in an increased charge per volume of the droplet.49 This 
phenomenon results in the production of multiply charged droplets. This represents one of 
the main advantages of ESI: the ability to perform MS measurements of large molecules with 
instruments with limited mass range, as multiply charged droplets correspond to a reduced 
m/z value for an analyte. However, for complex mixtures, the observed charge envelopes 
may overlap, resulting in difficulties identifying the components of the complex mixture.49 
Furthermore, ionization suppression can be an issue if multiple analytes are simultaneously 
electrosprayed, resulting in reduced sensitivity.50 Finally, the sensitivity of ESI has been 
observed to increase as the flow rate decreases, which makes coupling ESI with CE quite 
appealing, as the flow rates of CE typically range from the tens of nL/min to the low 
µL/min.51,52   Therefore, coupling ESI with liquid phase separations is very advantageous, as 
it provides a sensitive detector for the separation that yields mass and structural information, 
and the concerns about ionization suppression and charge envelope overlap are alleviated.  
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 Although CE and ESI share common properties, such as employing simple direct 
current circuits, strategies for the coupling of the two techniques must address several 
fundamental issues, including consolidation of the CE and ESI circuits, stable electric contact 
at the CE outlet electrode, proper emitter geometry for supporting stable ESI, and suitable 
electrolyte for separation and ESI.53 To date, the most common method for coupling CE and 
ESI is a sheath flow configuration that utilizes a coaxial arrangement of three concentric 
tubes. The inner tube is the separation column, followed by metal tubing for sheath liquid 
delivery, and finally outer tubing for the application nebulizer gas. The sheath liquid 
establishes electrical contact between the metal sheath flow tube, which functions as the CE 
outlet electrode and the electrospray emitter.53 Unfortunately, this arrangement has two 
significant disadvantages. First, the high flow rate of sheath liquid dilutes the CE effluent, 
resulting in decreased sensitivity. Second, the application of a nebulizing gas causes a suction 
effect at the outlet of the CE capillary, introducing parabolic flow and decreasing the 
separation efficiency.53 In 2007, Moini introduced a porous tip emitter that performed CE-
MS without the use of sheath flow.54 The porous sprayer tip is made by etching a segment of 
the capillary outlet, which permits the transport of small ions across the porous wall. The 
porous tip is then inserted into a metal sheath filled with BGE. A second capillary is inserted 
into the sheath, and an applied voltage forms the electric connection at the outlet of the CE 
separation capillary.54 This approach reduces the dilution effect of using a sheath flow, and 
has been applied to a number of different analytes including small molecules, peptides, and 
proteins.55-57 
1.5 Microfluidic Devices 
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Another strategy for coupling CE with ESI is to use a microfluidic device. Microchips, 
or lab-on-a-chip technologies, were developed in the early 1990’s and popularized by 
Ramsey and co workers.58-62 Microfluidic devices utilize the advancements in 
microfabrication techniques available for the microelectronics industry to generate tools for 
chemical sensing and analysis.60 In 1994, Jacobson et al. demonstrated a microchip 
monolithically etched in glass for performing CE with optical detection.60 Microfluidic 
devices have many advantages when compared with bench top instruments, including high 
speed,58,63 precise control of small sample volumes with no dead volume,64,65 low reagent and 
sample volume requirements,65,66 small physical footprint,60-62,64 the ability to integrate 
multiple components onto a single device,64,67,68 and the ability to automate the necessary 
steps of chemical analysis.67,69,70 Furthermore, the ability to automate many of the analysis 
steps leads to improvements in reproducibility, and can result in enhanced performance.65,71 
Since the initial descriptions in the early 1990’s, microfluidic devices have been applied to 
dozens of different applications, and their potential for improving the analysis of biological 
samples has been thoroughly investigated.   
 In 2008, Mellors et al. demonstrated an integrated microfluidic device coupling CE 
with ESI.41 The electrospray emitter was formed by terminating the CE separation channel at 
the corner of the microfluidic device. The 90 angle of the corner focused the spray in the X 
and Y dimension, and the thickness of the glass (300 µm) focused the spray in the Z 
dimension.41 Figure 1.1 illustrates a schematic of an integrated CE-ESI microchip. The 
reservoirs correspond to sample (S), BGE (B), waste (W), and electroosmotic pump (EO). 
ESI was generated by coupling the CE separation channel to an EO pump channel just prior 
to the ESI emitter. A difference in surface coating between the separation channel and the EO 
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pump channel resulted in differences to the EOF, which generated pressure driven flow to 
force fluid out of the ESI emitter. The EO pump channel also served to complete the CE 
circuit and control the voltage applied to the ESI emitter.41 The design by Mellors et al. 
combines the benefits circumventing sheath flow for CE-MS as well as the numerous 
advantages of microfluidic devices.  
 
 
Figure 1.1 Schematic of integrated CE-ESI microchip. Reservoirs correspond to sample (S), BGE (B), 
waste (W), and electroosmotic pump (EO). The ESI emitter is formed by terminating the separation 
channel at the corner of the device. ESI is performed by varying the surface coatings in the separation 
channel and EO pump cannel, resulting in a mismatched EOF that generates pressure driven flow. 
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Since the initial description by Mellors et al., the integrated CE-ESI microchip has 
been demonstrated to be a powerful tool for the analysis of biological samples. In 2010, 
Mellors et al. described a method for using the device to analyze the contents of cells lysed 
on chip.65 Chambers et al. demonstrated the coupling of microchip CE-ESI with a 
monolithically integrated LC column for a multi-dimensional separation of complex peptide 
mixtures.64 Batz et al. described a novel method for surface coatings in microfluidic 
devices.71 The improved surface coatings, as well as the reduction of other band broadening 
sources by using microchips such as injection and detector broadening,60 resulted in near 
diffusion limited separations.71 Redman et al. described a microfluidic CE-ESI method for 
the resolution of intact monoclonal antibody variants.72  
1.6 Work Described In This Thesis 
 This thesis describes the development of microfluidic CE-ESI instrumentation and 
methodologies aimed at improving the analysis of biological samples. The work described 
here builds upon the previous investigations of microchip CE-MS, and seeks to expand the 
capabilities and the methodologies to new applications, as well as enhancing performance 
related to existing applications. Chapter 2 describes the coupling of microchip CE-ESI with a 
commercial LC column to form a multi-dimensional separations platform. The LC-CE-ESI 
instrument was applied to a complex mixture of protein digests, and the figures of merit such 
as peak capacity and reproducibility were quantified. The tryptic digest of a monoclonal 
antibody was also analyzed, and the resulting chromato-electropherogram was used to 
characterize the glycosylation sites of the molecule. Finally, sampling concerns in both the 
CE and LC dimension were addressed by modifying the acquisition rate of the mass 
spectrometer. Chapter 3 explores the potential of microchip CE-ESI for the application of 
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hydrogen/deuterium exchange mass spectrometry (HX MS). The separation of a bovine 
hemoglobin pepsin digest was utilized to characterize the compatibility of an HX MS 
protocol with microchip CE-MS as well as quantifying the separation and mass spectrometry 
performance. A deuterium labeling experiment was performed to compare the deuterium 
retention of a microchip CE-MS method relative to an UPLC-MS method. A 270 kDa protein 
pepsin digest was also used to characterize the performance of the microchip CE-MS method 
for complex mixtures of large protein systems.  
Chapter 4 describes a method for performing low temperature microchip CE-ESI. The 
separation and electrospray performance was investigated at different temperatures, ranging 
from 30 °C to 0 °C. Furthermore, a proof-of-principle deuterium labeling experiment was 
utilized to demonstrate the potential of low temperature microchip CE-MS for HX MS 
applications. Chapter 5 describes a method for integrating sample processing with microchip 
CE-ESI. A solid phase extraction (SPE) bed of porous reversed-phase particles was packed 
on the microchip. A mixture of 4 peptides was used to probe the separation and pre-
concentration performance of the device. A transient isotachophoresis step was added to 
minimize broadening during the transfer step between the SPE bed to the CE separation 
channel. Furthermore, phosphorylase B and E. Coli tryptic digests were used to demonstrate 
the ability of the integrated SPE-tITP-CE-ESI device for characterizing complex mixtures. 
The desalting performance of the device was also investigated using a phosphorylase B 
tryptic digest. Chapter 6 discusses the future work and potential next step for each associated 
project.  
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CHAPTER 2: A HYBRID CAPILLARY/MICROFLUIDIC SYSTEM FOR 
COMPREHENSIVE ONLINE LIQUID CHROMATOGRAPHY-CAPILLARY 
ELECTROPHORESIS-ELECTROSPRAY IONIZATION-MASS SPECTROMETRY 
2.1 Introduction 
In recent years, the investigation of biological samples has trended towards the 
analysis of increasingly complex samples. Bottom up or shotgun proteomics is a salient 
example, where the entire proteome of a tissue sample, cell, or organism is digested into 
peptides and subsequently separated and analyzed with mass spectrometry.1,2 PeptideCutter 
is a software program that predicts potential cleavages sites by protease enzymes. It estimates 
that the tryspin digest of just a single 70 kDa protein, Bovine Serum Albumin, results in 
roughly 80 peptide fragments. Therefore, the resulting peptide mixture of an entire proteome 
could contain 1,000’s, 10,000’s, or even 100,000’s of components. Many other applications 
are targeting samples of similar complexity, such as hydrogen exchange mass 
spectrometry,3,4 metabolomics,5,6 and therapeutic drug monitoring,7,8 to name a few. 
Unfortunately, one-dimensional separation methods, such as liquid chromatography (LC) and 
capillary electrophoresis (CE), lack the resolving power to fully resolve such complex 
mixtures.9,10 
Peak capacity (nc), a metric for quantifying the resolving power of a separations 
method, is defined in Equation 1, where X is the separation window and 4σ corresponds to 
the average full width at base of the peaks in the separation.11  
!!!!!!!! nc = X4σ !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!(Eq.!1)!
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Peak capacity corresponds to the number of peaks that can fit in a given separation 
space while maintaining a resolution of 1. A typical Ultra Performance Liquid 
Chromatography (UPLC) separation coupled with mass spectrometry (MS) detection can 
achieve a peak capacity of around 400 for a peptide mixture.12-14 Busnel et. al. observed a 
peak capacity of 193 using a sheathless porous tip emitter CE-ESI instrumental setup.15 
However, the metric of peak capacity is a theoretical calculation of the number of 
components that can be resolved by a given separations method, and represents an ideal 
scenario. In practice, the number of components that can be fully resolved in the separation 
domain will be some fraction of the reported peak capacity. Davis and Giddings estimated 
that the number of single components that could be resolved was on the order of 10% of the 
reported peak capacity.11 This decreases the number of resolved components of UPLC-MS 
and CE-MS to between 20 and 40, not even sufficient to resolve the peptides from a typtic 
digest of one moderately sized protein. Increasing the separation efficiency (N) will improve 
the observed peak capacity for a separations technique. However, Equation 2 illustrates the 
square-root dependence between nc and N.11 
nc ≅
1
2 N                                           (Eq. 2) 
 Drastic improvements of the separation efficiency are required in order to make a 
significant increase to the observed peak capacity. From the earlier example, Busnel et. al. 
achieved a peak capacity around 200 with an applied voltage of 30 kV.15 In CE, the 
efficiency of a separation is linearly proportional to the applied voltage.16 Therefore, a 10 
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fold improvement in the observed peak capacity would require roughly a 200 fold 
improvement in the observed N, requiring 6 MV of applied voltage. A similarly dramatic 
increase in applied pressure and reduction of particle diameter would be required to increase 
the peak capacity of a UPLC separation by just an order of magnitude.13 While future 
improvements to both methods will surely increase the observed efficiency, it is unlikely that 
one dimensional separations methods will ever have the resolving power to tackle such 
complex mixtures in applications like proteomics.  
 One method for increasing the number of components that can be resolved is to 
perform a comprehensive multi-dimensional separation. A comprehensive multi-dimensional 
separation couples two or more separations techniques in series, and all components of the 
first-dimension are transferred to the subsequence dimension. This differs from ‘heart-cutting’ 
multi-dimensional separations, where only select analytes are transferred to the later 
dimensions.10 Multidimensional separations can be very powerful techniques, because the 
total peak capacity of the method is the multiplication of the peak capacity of each individual 
separation.10 For example, if the peak capacity of the first-dimension was 10 and the peak 
capacity of the second dimension was 20, the total peak capacity of the system would be 200. 
However, in order to achieve the maximum peak capacity of the system, certain conditions 
must be met. First, the different separation methods must be orthogonal, or based on different 
physical and chemical properties. Second, any resolution gained in the first-dimension must 
be maintained throughout the following dimensions. This means that samples cannot remix 
downstream of the first-dimension at any point, and the first-dimension must be sampled 
with a sufficient frequency to prevent undersampling. In practice, this requires that the 
second-dimension must be much faster than the first-dimension. Based on these criteria, 
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coupling LC in the first-dimension with CE in the second-dimension is a promising platform 
for a comprehensive multi-dimensional separation. LC separates analytes based on 
hydrophobicity while CE separates analytes based on electrophoretic mobility, and CE is 
typically much faster than LC separations, which aids in the sampling of the first-dimension 
LC peaks.10      
Microfluidic devices have advantages over conventional hardware for integration of 
numerous functional elements and rapid, precise manipulation of small volumes.17 These 
properties make them an ideal platform for multidimensional separations as demonstrated by 
several microfluidic systems utilizing different combinations of separation modes that have 
been reported.18-25 Many of the reported methods were capable of rapid and powerful 
separations, but without mass spectrometry (MS) detection they had limited practical utility.       
We recently developed a method for coupling microfluidic devices to MS detection 
via monolithic integration of an electrospray ionization (ESI) emitter.26 Highly stable and 
sensitive ESI-MS was realized without broadening the narrow, low volume analyte bands 
produced by microfluidic separations. Using this ESI interface we created a monolithic 
multidimensional separation system with liquid chromatography (LC), capillary 
electrophoresis (CE), and ESI integrated on a single microfluidic device.27 Used for online 
LC-CE-MS, this system yielded far better performance than previously reported capillary-
based systems.28-30  
Although the fully integrated LC-CE-MS system clearly demonstrated the advantages 
of microfluidics for multidimensional separations, we found that integration of the LC 
column within the microfluidic device limited the performance of the system. The fittings 
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that connected the device to an external pressure source could not reliably hold more than 
200 bar. This limited the minimum stationary phase particle diameter and column length, and 
therefore the efficiency of the LC column. It also necessitated manually packing each device 
with stationary phase particles. This increased fabrication time and could decrease device to 
device reproducibility. Moving the LC column off of the device and using a conventional 
capillary LC column alleviated these problems. The potential drawback to such a hybrid 
system would be dead volume band-broadening in the capillary to microchip connection. The 
same capillary to microchip fittings described in our previous work27 had sufficiently low 
dead volume (less than 20 nL) that band-broadening through the connection was not a 
limiting factor for the hybrid approach described below. 
Previous demonstrations of LC-CE and LC-CE-MS have used peptide mixtures to 
characterize system performance.22,27-39 It has been suggested that the two-dimensional image 
plot from an LC-CE separation of tryptic peptides could be used as a protein 
fingerprint,28,31,32,34,37 but a real world application of this technology has not yet been 
demonstrated. One application that might benefit from the unique capabilities of LC-CE-MS 
is the mapping of post translational modifications of complex biotherapeutics. For this work, 
we chose to characterize the N-linked glycosylation of a monoclonal antibody by 
glycopeptide mapping.40,41 It has been shown that one-dimensional LC-MS can be used for 
this application. Specifically, LC-MS/MS of tryptic digests can identify multiple 
glycosylation sites, determine the percentage of site occupancy, and quantify the relative 
abundance of each glycoform at multiple sites.42,43 LC-CE-MS can improve this method by 
two ways: first, by separating the glycopeptides from all other sample components in less 
time and with less method development; and second, by improving glycopeptide 
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identification confidence by using LC retention and CE migration times to confirm identity. 
In this work we evaluate the peak capacity and reproducibility of the hybrid LC-CE-MS 
system by separating a complex mixture of tryptic peptides. We then demonstrate an 
application of this system by mapping the N-linked glycosylation of a monoclonal antibody 
with two N-linked glycosylation sites. Finally, we illustrate that improvements to the mass 
spectrometer acquisition rate result in increase data sampling in both the CE and LC 
dimensions.     
2.2 Experimental 
2.2.1 Reagents and Materials 
Acetonitrile (Optima LC/MS), 2-propanol (Optima LC/MS), formic acid, and 
potassium hydroxide were obtained from Fisher Chemical (Fairlawn, NJ). Water was 
purified by a Nanopure system fitted with a 0.2 mm filter (Barnstead International, Dubuque, 
IA). 3-aminopropyltriethoxysilane, trichloro(1H,1H,2H,2H-perfluorooctyl)silane, and protein 
standards (bovine serum albumin, ovalbumin, enolase, and alcohol dehydrogenase) were 
acquired from Sigma Chemical Co. (St. Louis, MO). Sequencing grade modified trypsin was 
from Promega (Madison, WI).   
A mixture of 5 trypsin digested proteins was prepared as follows: Equimolar amounts 
of 4 proteins (bovine serum albumin, ovalbumin, enolase, and alcohol dehydrogenase) were 
denatured with guanidine hydrochloride at 60 °C. Proteins were then reduced with 
dithiothreitol, alkylated with iodoacetamide, and digested with trypsin for 4 h at 37 °C. After 
digestion, peptides were collected by solid phase extraction on an Oasis HLB cartridge 
(Waters Corp.) A phosphorylase B tryptic digestion standard (massPrep, Waters Corp.; 
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Milford, MA) was added as an internal standard. The mixture was then diluted with 3% 
acetonitrile, 0.1% formic acid to an approximate concentration of 500 nM for the 4 in-house 
digested proteins and 200 nM for phosphorylase B. 
A tryptic digest of an immunoglobulin G2 (IgG2) monoclonal antibody was provided by 
Pfizer Inc. using the following procedure: The IgG protein sample was diluted to 4.0 mg/mL 
with 20 mM sodium acetate (pH 5.5). Typsin was activated and diluted according to the 
manufacturer’s recommendations, then 100 mL of diluted protein solution was added to 50 
mL of acetonitrile, 10 mL of 500 mM Tris buffer (pH 8.5), and mixed well. The mixture was 
transferred to a vial containing 20 mg of resuspended trypsin and incubated for 24 h at 37 °C. 
At the end of incubation, 10 mL of 1N HCl was added to the mixture and mixed well to 
quench the digestion. Samples were diluted to a concentration of approximately 0.1 mg/mL 
with 3% acetonitrile, 0.1% formic acid before analysis by LC-CE-MS. 
2.2.2 Microchip Design and Fabrication 
  The microfluidic device (shown schematically in Figure 2.1) incorporated five 
distinct functional elements: a pressure-driven flow splitter, a CE injection cross, a CE 
separation channel, an electroosmotic pump, and an ESI emitter. The addition of the flow 
splitter is the only fundamental difference between this design and our previously described 
CE-ESI devices.26 The flow splitter was necessary to decouple the LC and CE flow rates, so 
both dimensions could be optimized. For this LC-CE-MS system the channel dimensions 
were designed so that 1/3 of the pressure-driven LC eluent would be directed to the injection 
cross. All channels were etched to a depth of 10 µm. Channel lengths were: LC inlet before 
split, 13 mm; LC inlet after split, 4 mm; split flow, 13 mm; background electrolyte (BGE), 8 
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mm; waste, 8 mm; CE channel, 91 mm; EO pump, 22 mm. The short channel segment 
between the EO pump intersection and the ESI corner was less than 0.2 mm long (not visible 
in Figure 2.1).   
 
Figure 2.1.  Schematic of the hybrid capillary LC-microchip CE-ESI experimental setup with a 9 cm 
long separation channel. The orange line represents a transfer capillary connecting the LC column to 
the microfluidic device. The dashed green lines represent electrical connections between the high 
voltage power supply and the microfluidic reservoirs. The device was positioned with the ESI corner 
approximately 5 mm from the mass spectrometer inlet. Channel dimensions are given in the 
experimental section.  
Straight channel segments were 95 µm wide at full width except for the split flow 
channel, which was broadened to 295 µm to decrease the hydrodynamic resistance and thus 
control the pressure driven flow split. The serpentine turns in the CE channel were 
asymmetrically-tapered down to a full width of 30 µm to minimize band-broadening, as 
previously described.26,44     
The microfluidic device was fabricated by standard photolithography and wet 
chemical etching methods as described previously.26,45 The device was fabricated from 0.15 
mm thick borosilicate glass substrates (Thermo Fisher Scientific, Portsmouth, NH), coated 
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with chrome and photoresist by Telic Co. (Valencia, CA). Access ports for the LC inlet and 
fluid reservoirs were drilled through the etched substrate using a Microblaster powder blaster 
(Comco Inc., Burbank, CA) fitted with a 0.38 mm i.d. nozzle. After bonding the etched 
substrate to a cover plate, the electrospray tip was machined by dicing the corner of the 
device with a precision saw (Dicing Technology, San Jose, CA) as previously reported.26 To 
protect the device from mechanical damage, the device was attached to 0.9 mm thick glass 
with transparent UV epoxy (Norland Products Inc., Cranbury, NJ). Glass cylinder solvent 
reservoirs (200 µL capacity) were attached to the device with a chemical resistant epoxy 
(Loctite E-120HP Hysol, Henkel Corp., Rocky Hill, CT).  
2.2.3 Surface Modification 
All internal and external surfaces of the microfluidic device were coated with 
aminopropyltriethoxysilane (APTES) using a gas phase deposition method. The covalently 
bound aminopropyl groups gave these microchannels a positive surface charge, providing 
anodic electroosmotic flow (EOF). A full description of this coating method along with a 
detailed characterization of the surface is currently in production. Briefly, microfluidic 
channels were prepared by flushing for 15 min with a mixture of 1N potassium hydroxide in 
80% by volume 2-propanol (KOH/IPA). Flushing was accomplished by attaching a vacuum 
line to the ESI corner of the device. The channels were thoroughly rinsed with deionized 
water and dried. The microchip was then placed in the chamber of a LabKote vapor 
deposition system (Yield Engineering Systems, Livermore, CA), heated to 130°C. After 
purging the chamber with nitrogen, the chamber was evacuated to a base pressure of 0.1 Torr. 
APTES (0.3 mL) was then injected into the chamber, raising the chamber pressure to ~1.5 
Torr. After a 30 min exposure the pressure was cycled and another injection was performed. 
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A total of 3, 0.3 mL reagent injections and 3, 30 min exposures were performed. Finally the 
chamber was purged with nitrogen to remove excess reagent vapor and the microfluidic 
device was removed. After silanization, the EO pump channel was selectively flushed with 
KOH/IPA for 2 h to remove the aminopropyl silane coating. The other channels were filled 
with 2-propanol during this process. The device was then flushed thoroughly with deionized 
water and the surface of the electrospray tip was coated with trichloro (perfluorooctyl) silane 
to prevent wetting and droplet formation as previously described.27,46 The same microfluidic 
device was used over a 4 week period without further surface treatment to collect all data 
presented in this manuscript. 
2.2.4 Liquid Chromatography 
A nanoAcquity UPLC system (Waters Corp., Milford, MA) was used for the LC 
separations. The analytical column (Waters part number 186003543) was 150 mm long, 75 
µm i.d., packed with 1.7 µm BEH130 C18 particles. The trapping column (Waters part 
number 186003514) was 20 mm long, 180 µm i.d. packed with 5 µm symmetry C18 particles. 
Mobile phase A was 0.5% acetonitrile with 0.1% formic acid, while mobile phase B was 
99.5% acetonitrile with 0.1% formic acid. The mobile phases were degassed by sonication 
under vacuum before use. During the 2 min trapping step, the mobile phase composition was 
1% B with a flow rate of 10 µL/min. The injection volume for all data presented here was 2 
mL. A 60 min gradient from 7% to 40% B at a flow rate of 500 nL/min and an analytical 
column temperature of 35°C was used for all separations presented. For LC-MS, the transfer 
capillary leading from the analytical column was connected to a 10 mm i.d. Picotip emitter 
(New Objective, Woburn, MA) via a Universal Nanoflow Sprayer interface (Waters Corp., 
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Milford, MA). For LC-CE-MS, the transfer capillary leading from the analytical column was 
connected to the microfluidic device using a previously described custom fitting.27 
2.2.5 Microchip Operation 
 The electrokinetically-gated CE injection method has been previously described.27 
Electric potentials were applied to the fluid reservoirs from a custom built power supply 
which was computer controlled using an in-house written LabVIEW program (National 
Instruments, Austin, TX). Appropriate safety precautions should always be taken when 
working with high voltage. CE injections were performed by periodically altering the 
voltages to allow small plugs of the LC eluent into the CE separation channel. When the CE 
injection gate was closed the voltages applied to the reservoirs (illustrated in Figure 2.1) 
were: BGE, -6 kV; waste, -3 kV; EO pump, +4.6 kV. In this state, flow from the BGE 
reservoir flowed down the CE separation channel and gated the LC eluent to waste. When the 
CE injection gate was open the voltages applied to the reservoirs were: BGE, -4.75 kV; waste, 
-4.25 kV; EO pump, +4.6 kV. The field strength in the separation channel was the same for 
both voltage states, so overlapping injections34 could be used without perturbing the previous 
separation. Injections lasting 0.1 s were performed every 10 s. The CE injection cycle was 
initiated before the sample was injected onto the LC column and continued through the 
duration of the run. To insure proper timing over long periods of time, an external function 
generator (Agilent Technologies model 33220A) was used to trigger the CE injections. The 
BGE for the CE separations was 50% acetonitrile, 0.1% formic acid. The voltages applied to 
the microfluidic reservoirs provided an electrophoretic separation field of approximately 800 
V/cm, and an ESI voltage of +3 kV. The difference in EOF between the APTES coated 
separation channel and the uncoated EO pump channel caused fluid to be pumped out of the 
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ESI orifice at approximately 400 nL/min (350 nL/min anodic flow from the separation 
channel plus 50 nL/min cathodic flow from the EO pump channel). 
2.2.6 Mass Spectrometry 
 An LCT Premier orthogonal acceleration time-of-flight (oa-TOF) mass spectrometer 
was used (Waters Corp.). Data were acquired in V mode from 300 – 1600 m/z at a rate of 10 
Hz (90 ms per summed scan with an interscan delay of 10 ms). The microchip was held on 
an x,y,z translational stage and positioned with the electrospray corner approximately 5 mm 
from the inlet of the mass spectrometer as previously described.26 The MassLynx data 
collection software was triggered to begin saving at the first CE injection after the LC 
injection. Data collection continued as a single file for the duration of the LC-CE-MS run. 
2.2.7 Data Processing 
LC-CE-MS data were processed into 2D image plots as described previously.27 
Briefly, data were exported from MassLynx as two columns (LC run time and ion count). A 
Labview program was used to generate a third data column representing CE migration time. 
The program worked by performing iterative subtraction of the time between CE injections 
(10 s) from the original LC run time data until all data points had a value between 0 and 10 s. 
The actual dead time of the CE runs was about 2 s longer than the CE injection period, so the 
original run time data points were all shifted by -2 s to properly center the time window. Due 
to this shift and the use of overlapping injections, this method produced CE migration time 
values that were 12 s lower than the actual CE migration times. These 12 s were added back 
when the data were plotted. The three data columns (CE migration time, LC run time, and 
ion count) were loaded into an open source imaging program (Image J, U.S. National 
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Institutes of Health, available at http://rsb.info.nih.gov/ij) with an available plugin 
(XYZ2DEM importer). The resulting image was loaded into Igor Pro (WaveMetrics, Lake 
Oswego, OR) for additional graphing options.   
 Data from the LC-CE-MS separation of the monoclonal antibody were additionally 
processed using BiopharmaLynx version 1.2 (Waters Corp.). We used a method designed for 
LC-MS peptide mapping, modified to search for a peak width of just 0.01 min with an MS 
threshold of 100 counts. The amino acid sequence and disulfide linkages of this molecule 
were provided by Pfizer Inc. The modifications search included the common N-linked 
glycosylations illustrated in Figure 2.2.  
 
Figure 2.2. Structures of common N-linked glycans examined in this manuscript.   
BiopharmaLynx was not designed to process multidimensional data, so the software 
processed the LC-CE-MS data as if it were LC-MS data. It identified each LC-CE-MS peak 
as a separate component, assigning the same molecular mass and peptide identification to 
multiple peaks. In other words the peak matching algorithm did not use CE migration time 
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data to help it identify peaks, but it was also not confused by the presence of multiple narrow 
peaks with the same molecular mass. The relative abundance of each glycoform was 
calculated by a manual summation of the total MS intensity for all peaks assigned to each N-
linked glycopeptide. The LC retention and CE migration times were found by generating a 
separate 2D image plot using extracted ion chromato-electropherograms for each identified 
N-linked glycopeptide.  !
2.2.8 High MS Acquisition Rate LC-CE-ESI 
To increase the data sampling rate in the MS dimension and to reduce undersampling 
concerns, firmware modifications were made to a Waters Synapt G2 mass spectrometer 
(Waters Corporation). The Synapt G2 is capable of performing a multi-dimensional 
separation with a high MS acquisition rate: LC coupled with ion mobility spectrometry 
(IMS) followed by MS detection. We repurposed the LC-IMS-MS functionality of the 
instrument and performed LC-CE-MS. To accommodate a faster CE separation, a LC-CE 
microchip was fabricated with a 4.3 cm separation channel. A schematic of the device can be 
seen in Figure 2.3. Aside from the length of the separation channel, the dimensions and 
operate of the device were very similar to those reported in Figure 2.1. The fabrication and 
surface modification of the 10 cm and 4.3 cm devices were identical. For operation of the 4.3 
cm device, voltages of +2.6, + 0, and + 6.6 kV were applied to the BGE, Waste, and EO 
pump reservoirs, respectively. To inject sample into the separation channel, the voltages were 
changed to +1.3, + 1.3, + 6.6 kV, respectively. A 40 ms CE injection was performed every 4 
s, and was initiated by the mass spectrometer as opposed to a function generator. 
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Figure 2.3.  Schematic of the hybrid capillary LC-microchip CE-ESI experimental setup with a 4.3 
cm long separation channel. The orange line represents a transfer capillary connecting the LC column 
to the microfluidic device. The dashed red lines represent electrical connections between the high 
voltage power supply and the microfluidic reservoirs.  
The mass spectrometer scanned a range of 325 – 1600 m/z at an acquisition rate of 50 
Hz. The sample used was a Waters MassPREP Protein Expression Mix (Waters Corporation), 
which contained 400 nM bovine serum albumin, 100 nM enolase, 50 nM alcohol 
dehydrogenase, and 25 nM phosphorylase B. The UPLC instrument, column, and mobile 
phases were the same as reported earlier. The injection volume was 2 µL, the flowrate was 
500 nL/min, and the gradient was 7 – 40% B in 15 min. Data were analyzed using the 
software program Driftscope (Waters Corporation).   
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2.3 Results and Discussion 
2.3.1 Evaluation of System Performance 
The LC-CE-MS system was evaluated for total peak capacity and reproducibility 
using the 5-protein tryptic digest. For comparison this sample was separated by LC-MS and 
LC-CE-MS using identical LC conditions. The base peak ion count (BPI) chromatogram for 
the LC-MS run is displayed along with the BPI chromato-electropherogram for an LC-CE-
MS run in Figure 2.4. 
 !!
Figure 2.4. LC-MS chromatogram (A), and LC-CE-MS chromato-electropherogram (B/C) for the 
analysis of a 5-protein tryptic digest mixture. All LC conditions and MS acquisition settings were 
identical for these two runs. The bottom plot (C) is an expanded view of a segment of the data shown 
in B. The dashed lines indicate when CE injections were performed, with labels to indicate the 
injection number.   
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The individual peaks of the LC-CE-MS run are too brief to see in Figure 2.3B, so a 1-
min wide section of this run is displayed in Figure 2.4C. The peaks from sequential CE runs 
can be clearly seen, spaced by the 10 s period of the CE injections. Dashed lines indicate the 
times at which the labeled CE injection number occurred. Because overlapping injections 
were used, the peaks are offset by 1 injection period. In other words, the first group of CE 
peaks visible in Figure 2.4B came from injection number 173, and the peaks from injection 
number 179 are not visible in this figure. Figure 2.5 shows a two-dimensional image plot 
generated from the same data displayed in Figure 2.4B. This plot gives a better representation 
of the power of this multidimensional separation. In this plot the color of the spots 
corresponds to the intensity of the base peak ion count. The position of each spot corresponds 
to its LC retention and CE migration times. Spot position therefore reflects the 
hydrophobicity and electrophoretic mobility of the detected compound.  
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!Figure 2.5. Image plot for the LC-CE-MS separation of a 5-protein tryptic digest mixture. This plot 
was generated from the same data shown in figure 2.3B.   
Comparison of extracted ion chromatograms for the LC-MS and LC-CE-MS 
separations of the 5-protein tryptic digest confirmed that the peptide bands had similar 
temporal widths in both runs (Figure 2.6). Identical LC runs were performed using a standard 
capillary spray tip interface and the microchip CE-ESI interface. By displaying a small m/z 
range and aligning the traces, we can compare the observed peak widths for peptide bands 
with and without the capillary to microchip transfer. Figure 2.6 shows that band widths and 
shapes were very similar for LC-MS and LC-CE-MS indicating that the capillary to 
microchip connection was not a major source of band broadening. Therefore, the LC-MS 
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separation of the 5 protein tryptic digest was used to estimate peak capacity for the LC 
dimension of the LC-CE-MS run.   
  
Figure 2.6.  Extracted ion plots for the LC-MS (red) and LC-CE-MS (black) separations of the 5-
protein tryptic digest. The LC-MS trace was shifted by +0.45 min to better align the peaks for better 
visual comparison; and the LC-CE-MS trace was shifted down by 20 counts to align the baselines.   
The LC-MS BPI chromatogram contained too many unresolved peaks to accurately 
measure peak widths, so an extracted ion chromatogram from a small m/z range (700 – 710) 
was used. This chromatogram was processed with an open source software program (Peak 
Finder, available at http://omics.pnl.gov/software) to estimate the median 4s peak width. A 
total of 30 peaks were fit, yielding a median peak width of 16.5 s. To calculate peak capacity, 
the full width of the LC separation window was determined from the LC-CE-MS data by 
subtracting the run time of the first observed peptide peak (~11 min) from the run time of the 
last observed peptide peak (~49 min). Dividing the LC separation window by the 4σ peak 
width gave an LC peak capacity of 138. The median CE peak width was determined by 
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processing the entire BPI chromato-electropherogram for the LC-CE-MS separation of the 5-
protein tryptic digest using the same software program. A total of 334 peaks above a 
threshold of 30 BPI were identified with a median peak width of 0.44 s. The average width of 
the CE separation windows was estimated by visual examination of the image plot shown in 
Figure 2.5 to be approximately 4.5 s. This average window divided by the median peak width 
of 0.44 s, yielded an average CE dimension peak capacity of 10.2. Multiplying the estimated 
peak capacities of the LC and CE dimensions yielded a total LC-CE peak capacity of 
approximately 1400; over an order of magnitude greater than the LC-MS run with negligible 
increase in analysis time. The reproducibility of the system was measured with 3 replicate 
LC-CE-MS runs of the same 5 protein tryptic digest sample (Figure 2.7) performed on the 
same day. The spot locations of ten randomly selected components were identified in the 
image plots for each replicate run. For these 3 replicate runs, the average relative standard 
deviations (RSD) for LC retention and CE migration times of these 10 spots were 0.32% and 
0.75%, respectively.   
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Figure 2.7.  Same day replicate LC-CE-MS separations of the 5 protein tryptic digest. The spot colors 
indicate base peak ion count. 
 
2.3.2 N-linked Glycosylation Analysis of a Monoclonal Antibody 
 After characterizing the performance of the LC-CE-MS system, the same method 
described above was applied to glycosylation profiling of a monoclonal antibody. The 
molecule studied was an immunoglobulin G2 (IgG2) with two heavy chain N-linked 
glycosylation sites, one in the Fc domain and one in the Fab domain. The sample was 
prepared by digestion with trypsin, but was not chemically modified in any other way. N-
glycans were therefore attached to one of two tryptic peptides (EEQFNSTFR from the Fc 
domain and NTSISTAYMELSSLR from the Fab domain). Figure 2.8 shows the 2D image 
plot generated from this analysis. The spots containing all of the observed N-linked 
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glycopeptides are circled on this plot. Unglycosylated tryptic peptides from each 
glycosylation site were also observed.   
 
Figure 2.8.  Image plot for the LC-CE-MS separation of a digested IgG2 containing two N-linked 
glycosylation sites. The circled spots contained all of the observed N-linked glycopeptides. The spot 
labeled A0 contained all of the glyopeptides from the Fc domain site. Spots B0, B1, and B2 contained 
the glycopeptides from the Fab domain site containing 0, 1, and 2 sialic acid residues, respectively. 
The positions of corresponding unglycosylated peptides from each site are indicated with asterisks (*).   
These two spots are not visible in Figure 2.8 because they were of low abundance and 
they both coeluted with other highly abundant peptides. However, their locations, determined 
from extracted ion plots, are indicated by asterisks. Table 2.1 lists all of the observed N-
linked glycopeptides along with observed masses, locations in Figure 2.8, intensities, and 
relative abundances. 
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Table 2.1.  N-linked glycopeptides observed by LC-CE-MS analysis of the IgG2 tryptic digest.   
Fc#Domain:#EEQFNSTFR#
N1glycana# Calculated#Mass# Observed#Mass# Spot#Locationb# Total# Intensity#(counts)# %# of#total#
aglyco# 1156.51# 1156.44# A# 539# 0.3%#
A1G0# 2251.91# 2251.78# A0# 266# 0.1%#
A1G0F# 2397.97# 2397.85# A0# 7613# 3.8%#
A2G0# 2454.99# 2454.86# A0# 5479# 2.7%#
A2G0F# 2601.05# 2600.90# A0# 154367# 76.1%#
A2G1F# 2763.10# 2762.95# A0# 25584# 12.6%#
A2G2F# 2925.15# 2924.98# A0# 486# 0.2%#
A2S1G1F# ## ## ## ## ##
A2S1G2F# ## ## ## ## ##
A2S2G2F# ## ## ## ## ##
M5# 2372.94# 2372.81# A0# 8414# 4.1%#
sum# ## ## ## 202748# 100.0%#
# # # # # #
Fab#Domain:#NTSISTAYMELSSLR#
N1glycan#
Calculated#
Mass#
Observed#
Mass#
Spot#
Location#
Total# Intensity#
(counts)#
%# of#
total#
aglyco# 1671.81# 1671.73# B# 2926# 4.6%#
A1G0# ## ## ## ## ##
A1G0F# 2913.27# 2913.10# B0# 412# 0.6%#
A2G0# ## ## ## ## ##
A2G0F# 3116.35# 3116.20# B0# 12503# 19.5%#
A2G1F# 3278.40# 3278.24# B0# 5187# 8.1%#
A2G2F# 3440.45# 3440.29# B0# 1928# 3.0%#
A2S1G1F# 3569.44# 3569.31# B1# 7254# 11.3%#
A2S1G2F# 3731.55# 3731.37# B1# 13733# 21.4%#
A2S2G2F# 4022.64# 4022.44# B2# 20310# 31.6%#
M5# ## ## ## ## ##
sum# ## ## ## 64253# 100.0%#aGlycan!structures!are!defined!in!Figure!2.2.!
b!Spot!locations!correspond!to!Figure!2.8.!!
A closer examination of the data displayed in Figure 2.8 and Table 2.1 indicates some 
important features of this separation. First we can see that all of the N-linked glycopeptides 
were fully resolved from other highly abundant peptides. The presence of intense spots at the 
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same horizontal or vertical position in the plot indicates that this would not have been the 
case for a one-dimensional LC or CE separation. Second, we can see that the glycopeptide 
spots are located in predictable regions relative to each other and their corresponding aglyco 
peptides. Neutral glycosylations (spots A0 and B0) shifted the position relative to the aglyco 
peptides (spots A* and B*) to earlier LC retention and CE migration times. As expected from 
the greater relative change in molecular mass, the shift was greater for the smaller Fc domain 
peptide (A). Except for the addition of a sialic acid residue, differences in N-glycan structure 
had little effect on LC retention or CE migration. The addition of each sialic acid residue 
caused a significant shift to earlier CE migration and later LC retention (spots B1 and B2 
compared to B0). Finally, we can see significant differences in the glycosylation profiles of 
the two different sites, as indicated by the different N-glycans observed in Table 2.1 as well 
as the location of the glycans corresponding to A and B in Figure 2.5. This highlights the 
importance of maintaining site specific information by analyzing glycosylation at the peptide 
level. 
 There are more than 100 fully resolved spots visible in Figure 2.8. This clearly 
indicates that far more information is available in this data than what has been analyzed here. 
To fully exploit the power of this technology, improved data analysis software is needed. We 
were able to generate 2D image plots from our LC-CE-MS data, but can only display a single 
ion count (total ion, base peak, or extracted ion counts) as the color scale in these plots. To 
access the wealth of MS data generated by this method we had to refer back to the linear raw 
data file. We were not able to sum spectra in the 2D separation space. There are programs 
designed for multidimensional gas chromatography (GCxGC)-MS (e.g. ChromaTOF, LECO 
Corp., St. Joseph, MI), and LC-ion mobility-time of flight-MS (e.g. DriftScope, Waters Corp., 
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Milford, MA) that can do this. Although we did not attempt to import our LC-CE-MS data 
into one of these programs, it should be possible. As mentioned above it should also be 
possible to use LC-CE spot position to help identify sample components. Peptide retention 
prediction has been integrated into bioinformatics software to improve identifications for 
one-dimensional LC-MS.47,48 The added specificity of an additional separation dimension 
should greatly improve this type of correlation. Retention indices have been used for sample 
component identification in GCxGC, with considerable effort applied to accurately 
predicting retention in both dimensions.49 Reichenbach et al. recently reported a method of 
peak pattern matching for two-dimensional liquid chromatography (LCxLC).50 Their method 
could be applied to LC-CE-MS data for automated comparison of different samples. Because 
CE migration (dependent only on molecular size and charge) is simpler than 
chromatographic retention, correlation to chemical structure should be easier and more 
precise for LC-CE, than for multidimensional methods that use two modes of 
chromatography.    
2.3.3 Increased Acquisition Rate LC-CE 
The previous work demonstrated the potential of coupling commercial LC with 
microchip CE-ESI to perform a fast and reproducible multi-dimensional separation with high 
resolving power. However, it was not without disadvantages; one of the disadvantages of the 
technique described is the lack of streamlined data processing software. While image plots of 
chromato-electropherograms could be produced, they did not easily provide access to the 
corresponding mass spectra of each component. An additional disadvantage of the technique 
was undersampling of both the first-dimension LC peaks (number of CE injections per LC 
peak) as well as the second-dimension CE peaks (number of MS data points per CE peak). In 
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order to maintain the resolution of the first-dimension separation, and therefore maintain the 
total peak capacity of the method, the first-dimension peaks must be sampled with a 
sufficient frequency by the second-dimension.10 This requires a minimum of 3 to 4 CE 
separations per LC peak.51 For the separation of the 5-protein tryptic digest (Figure 2.5), the 
median 4σ peak width in the LC dimension was 16.5 s. CE separations were performed every 
10 s, which means that the LC peaks were sampled only 1.6 times on average. Increasing the 
average LC peak width would alleviate this issue, however, that would result in either 
decreased peak capacity or increased analysis time, both of which are undesirable.  
Another option to improve the frequency of sampling the LC dimension would be to 
increase the sampling rate and perform CE injections more often. Because overlapping 
injections were used, the sampling frequency of the LC dimension was limited by the CE 
separation window. For the 5-protein tryptic digest sample, the median CE 4σ peak width 
was 0.44 s. With a MS acquisition rate of 10 Hz, each CE peak had 4.4 MS data points per 
peak on average, below the desired minimum of 6 data points per peak to properly 
characterize a Gaussian peak. To increase the sampling frequency of the LC dimension, the 
separation window in the CE dimension would have to decrease. In order to maintain peak 
capacity, the shorter CE separation window would necessitate narrower peaks, as peak 
capacity is defined as the separation window divided by the 4σ peak width.11 Unfortunately, 
the MS acquisition rate limited the overall CE peak width, and prevented faster CE 
separations from being performed. The acquisition rate of the MS could not be increased 
above 10 Hz without significantly decreasing the observed sensitivity, therefore, the 
frequency of sampling the LC peaks could not be increased without either reducing the peak 
capacity in the CE dimension or exacerbating the undersampling of the CE peaks by the mass 
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spectrometer. To alleviate both undersampling concerns, improvements to the MS 
instrumentation were required. 
 Working with our collaborators at Waters Corporation, we were able to modify a 
commercial mass spectrometer, the Waters Synapt G2, to increase the MS data acquisition 
rate and alleviate the undersampling concerns of the previous LC-CE-ESI work. The Synapt 
G2 is capable of performing LC-IMS-MS. In this case, we performed a firmware 
modification and repurposed the LC-IMS-MS functionality of the instrument to perform LC-
CE-ESI. To take advantage of the fast MS data acquisition and to increase the frequency of 
sampling the LC peaks, a LC-CE-ESI microchip was fabricated with a shorter separation 
channel of 4.3 cm. A schematic of this microchip can be seen in Figure 2.3. To illustrate the 
separation performance of this device, a 4-protein tryptic digest was analyzed. Figure 2.10 
shows an image plot of the chromato-electropherogram. In the LC dimension, a peak 
capacity of 32 was observed with a median 4σ peak width of 12 s. The gradient of the LC 
separation was shortened from 1 h to 15 min, which resulted in a lower total peak capacity 
than the previous LC separation. In the CE dimension, the CE separation window was 
shortened to 4 s from 10 s, and a peak capacity of 10.0 was observed with a median 4σ peak 
width of 0.22 s. The total peak capacity of the method was 320. By using the metric of peak 
capacity/min, we can compare the resolving power of this design with the previous work 
reported. For the separation of the 5-protein digest with the 10 cm device, a peak capacity of 
1400 was observed in 50 min, resulting in a peak capacity/min of 28. For the separation of 
the 4-protein digest with the 4.3 cm device, a peak capacity of 320 was observed in 17 min, 
resulting in a peak capacity/min of 18.8. While this is lower than the previous results, the 
decrease in peak capacity is mainly due to differences in the LC dimension, as the CE peak 
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capacity was similar in both methods (10.2 v 10.0). Because the LC separation used a 
commercial instrument and a commercial column, it is expected that by returning to the 
longer gradient, the performance of the previous LC separation could be replicated.      
       
Figure 2.9. Multidimensional image plot showing the LC-CE-MS separation of a 4-protein tryptic 
digest mixture. A total peak capacity of 320 was observed. 
 While the separation performance of both devices was similar, data sampling was 
significantly improved in the later version. After the modification to the Synapt G2, the MS 
data acquisition rate was increased to 50 Hz. Based on the median 4σ CE peak width of 0.22 
s, each CE peak had an average of 11 MS data points, more than double that of the previous 
work. The median 4σ LC peak width was 12 s. CE injections were performed every 4 s, 
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resulting in an average of 3 CE separations per LC peak, which meets the minimum 
requirement to effectively sample the first-dimension of a multi-dimensional separation.51 
Figure 2.10B and 2.10C illustrate the data sampling of representative LC and CE peaks, 
respectively.  
Data processing was another concern of the previous method. While image plots of 
the chromato-electropherograms could be generated, such as in Figures 5 and 8, these images 
did not easily provide access to the all of the information contained in the chromato-
electropherogram. The output of the data was a series of CE peaks, as seen in Figure 2.4. 
These data were processed in a Labview program and plotted using the software programs 
Image J and Igor Pro. However, the resulting image plots did not contain the corresponding 
mass spectra for each analyte in the chromato-electopherogram. Additionally, there was no 
straightforward way to search a constructed 2D image plot for a specific m/z value. To 
identify the location of a specific component, each image plot had to be reprocessed and 
remade, which was a time consuming process. Finally, the reconstructed LC chromatogram 
was unavailable, which could provide useful information in certain applications. Performing 
the LC-CE analysis with the modified mass spectrometer provides another benefit aside from 
improving the data sampling. The output of the data was compatible with Driftscope, 
commercial software from Waters meant to process LC-IMS-MS data. By using Driftscope, 
2D chromato-electropherograms could easily be generated without the processing steps 
required previously. The 2D plots generated had the ability to search for a given m/z value, 
illustrating where on the 2D plot that component was located. Additionally, the 
corresponding LC chromatogram and CE electropherogram for a specific component could 
be reconstructed, as well as the mass spectrum. Figure 2.10 illustrates a representative 2D 
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plot of a specific m/z value (689) from the 4-protein tryptic digest shown in Figure 2.9. 
Figure 2.10A illustrates the location of the component on the plot. Figures 2.10B and 2.10C 
illustrate the reconstructed LC and CE peaks, respectively, while Figure 2.10D illustrates the 
mass spectrum. Overall, the compatibility of the multi-dimensional data with the commercial 
software made data analysis and processing significantly easier. 
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Figure 2.10. Representative image plots illustrating the data handing capabilities of Driftscope 
software. A – Chromato-electropherogram mage plot showing the location of a specific m/z value 
(689 m.z). B – Plot illustrating the LC peak shape and data points per peak of the selected component. 
C – Plot illustrating the CE peak shape and data points per peak of the selected component. D – Mass 
spectrum showing the spectral data of the selected analyte.  
 
2.4 Conclusion 
A hybrid capillary LC-microfluidic CE-ESI system has been demonstrated for the 
LC-CE-MS analysis of digested proteins. This system yielded significant improvements in 
peak capacity and reproducibility compared to previous reports of LC-CE-MS.27-30 For a 5-
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protein tryptic digest, a peak capacity of 1400 was observed in 50 min. The glycosylation 
profiling method demonstrated here provides a good example of the type of application that 
could benefit from this new technology. Improving the mass spectrometer acquisition rate 
eliminated undersampling concerns in both the CE and LC dimensions. The use of 
commercial software designed to process and analyze multi-dimensional data significantly 
improved data analysis. The biggest advantage of this method may be the ability to easily 
convert an existing LC-MS system to a high peak capacity LC-CE-MS system. Connecting 
the microfluidic device to an LC column outlet is no more complicated than connecting a 
conventional ESI emitter; and CE separations can be performed by simple electronic control 
of three voltages. On chip flow splitting can accommodate a wide range of LC flow rates 
with minor adjustments to the microfluidic channel dimensions.  
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CHAPTER 3: UTILIZING MICOCHIP CAPILLARY ELECTROPHORESIS 
ELECTROSPRAY IONIZATION FOR HYDROGEN EXCHANGE MASS 
SPECTROMETRY 
3.1 Introduction 
  Proteins play a critical role in a number of biological processes including cellular 
signaling, gene expression, biochemical reaction catalysis, and apoptosis. Understanding the 
molecular basis of these and many other biological functions requires a thorough 
comprehension of the structure, dynamics and conformational changes of the proteins and 
protein complexes involved. This challenging task necessitates experimental techniques that 
can probe the fundamental characteristics of proteins and help elucidate the link between 
protein structure and function. In the past decades, this topic has been a great focus of 
researchers, and a variety of different approaches have been described including nuclear 
magnetic resonance,1,2 X-ray crystallography,3,4 small angle X-ray scattering,5,6 and cryo-
electron microscopy.7,8 These techniques have been extremely valuable for many areas, but 
they are not able to characterize all proteins including those that will not crystallize, those 
that are highly dynamic in solution, and especially those at and in membranes.  Other 
techniques capable of probing protein conformation and dynamics are therefore extremely 
valuable in protein analysis. Hydrogen exchange (HX) mass spectrometry (MS), offers great 
potential for analyses of protein complexes and large protein systems as it provides access to 
proteins other techniques struggle to analyze.9-10 HX MS does not necessitate protein 
crystallization, requires very little sample, is amenable to studying proteins that are difficult 
to purify, and can reveal conformational changes on a wide time scale.11 As a technique, 
however, it is not without its own set of challenges. 
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The basic strategy for HX MS derives from the original description of Rosa and 
Richards12 and consists of labeling proteins in their native state with deuterium, digesting the 
protein into peptides and quantifying the amount of deuterium uptake at different points 
along the amino acid backbone of the protein by observing a shift in mass. In proteins, the 
rate of hydrogen deuterium exchange is governed by essentially four factors: pH, temperature, 
solvent accessibility, and hydrogen bonding.11 As pH and temperature are experimentally 
controlled, the measured deuterium uptake indicates the degree to which that part of the 
molecule was exposed to the solvent and the amount of hydrogen bonding; thereby providing 
information about the folded structure of the molecule and interactions between regions of 
the protein and other molecules in solution.13 To conserve the information generated during 
the labeling step, it is necessary to perform the digestion and separation steps under quench 
conditions.14,15 This is typically achieved by lowering the pH to 2.5 and the temperature to 
0 °C. While these conditions significantly slow the rate of H/D exchange, they do not 
completely stop it, requiring the digestion and separation to be performed as quickly as 
possible, generally in less than 10 min. Further delay causes significant information loss 
through H/D back exchange. Liquid chromatography (LC) is the most common separation 
method for HX MS, and is often performed at low temperatures with fast gradients to 
minimize the amount of observed back exchange.  
  HX MS using LC as the separation method is robust for small proteins (<40-50 kDa) 
and for simple complexes of 1-2 components. However, it’s estimated that nearly every 
major biological process performed in cells is carried out by protein machines containing at 
least 10 protein molecules.16 The vast complexity of such targets requires new methodology 
and technology advances to truly uncover the relationship between structure, function, and 
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dynamics of protein complexes. To date, larger proteins and protein complexes (>150 kDa 
and 3+ members) remain difficult to study via HX MS because of the huge number of 
peptides that are generated upon digestion. The LC step does not generally provide adequate 
separation power (commonly quantified as peak capacity) to allow the large number of 
peptides generated to be clearly identified and characterized during a deuterium exchange 
experiment. Because the limiting factor preventing the analysis of increasingly complex 
samples lies with the limited resolving power of LC at low temperatures and fast run times, 
improving the separation power is pivotal for expanding the scope of analyzing biological 
systems using HX MS. 
While it has been used for HX MS out of convenience and availability, liquid 
chromatography is not ideally suited to fast separations at low temperature because it is 
limited by resistance to mass transfer (the van Deemter C-term). Even the most state of the 
art, modern Ultra Performance Liquid Chromatography (UPLC), performed under quench 
conditions, cannot achieve a peak capacity much greater than about 60.17 Higher peak 
capacity could be obtained with a longer LC separation, but only at the expense of greater 
deuterium loss, which is not an acceptable alternative. One way to improve these LC 
separations without increasing the run time would be to use smaller stationary phase particles, 
but the back pressure required to operate such LC columns would be excessively high and 
difficult to achieve with commercial systems.18 Another possibility is to keep separation time 
constant while increasing the flow rate and making the solvent gradient more shallow.  Again, 
this increase in flow rate leads to higher backpressure that may not be easy to achieve.  If a 
different separation modality were available, with superior performance at low temperate, 
HX MS separations could be improved.  
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Free zone capillary electrophoresis (CE) separations have been used for HX MS 
characterization of standard peptides,19 however its application to protein digests remains to 
be investigated. CE is very fast, efficient, and is not limited by resistance to mass transfer. In 
the absence of extra-column band-broadening, analyte-wall interactions, surface coating 
heterogeneity, and joule heating (all of which are minimized in microfluidic devices), the 
efficiency of a CE separation is determined only by the voltage applied and the 
temperature.20,21 Equation 1 illustrates the relationship between the number of theoretical 
plates, N, and the applied voltage, V, where D is the diffusion coefficient of the molecule and 
µ is the electrophoretic mobility.20 It is theoretically possible to achieve the same separation 
efficiency and peak capacity in any amount of time by varying the length of the separation 
column while holding constant the voltage applied. 
 
                                                                                                 (1) 
 
Equation 2, the Stokes-Einstein equation, defines a spherical molecule’s diffusion 
coefficient, where k is Boltzmann’s constant, η is the solvent viscosity, r is the radius, and T 
is the temperature.22 Equation 3 defines the electrophoretic mobility of a molecule, where q is 
the charge of the molecule.23  
 
                                                                                              (2) 
 
N = µV2D
D = kT6πηr
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                                                                                              (3) 
 
Substituting Equations 2 and 3 into Equation 1 results in Equation 4, revealing the 
inverse temperature dependence of the separation efficiency for a CE separation. 
 
                                                                                                (4) 
 
As Equation 4 reveals, cooling a CE separation will improve the separation efficiency. 
However, at constant applied voltage, the overall run time will increase at lower temperatures 
due to an increase in solvent viscosity.24,25 Increasing the voltage to offset the increased 
viscosity will reduce the migration time, keeping run time constant and further improving the 
efficiency of the separation.  
We have demonstrated a microfluidic platform for performing very fast and highly 
efficient CE separations coupled with electrospray ionization (ESI).26,27 The improved speed 
and peak capacity of this platform offers many potential benefits for HX MS such as 
expanding the types of proteins and protein complexes able to be analyzed and reducing back 
exchange. Furthermore, microfluidic technology is extremely well suited towards integration 
of multiple functional elements,28,29 such as online digestion and peptide concentration, 
resulting in the prospect of a fully integrated microchip CE-ESI system for HX MS 
analysis.30  
In this work, we demonstrate the fundamental utility of applying microchip CE-ESI 
devices towards HX MS. Microchip CE-ESI was used to analyze a pepsin digestion of the 
€ 
µ =
q
6πηr
€ 
N = qV2kT
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model protein bovine hemoglobin. The speed, peak capacity, and reproducibility of the 
separation were optimized with all the limitations of HX MS in mind. Each parameter was 
characterized and these metrics were compared to the separation of an identical mixture 
using a UPLC system. Data independent MS/MS was also performed to determine how 
peptide identification would perform with such short duration peaks from the microchip CE-
ESI method. The deuterium recovery of the CE and LC methods were compared.  Finally, the 
utility of the method for large complex systems was examined by using microchip CE-ESI to 
separate a 3 protein mixture consisting of 270 kDa of unique sequence.  
3.2 Experimental 
3.2.1 Reagents and Materials 
LC-MS grade acetonitrile and formic acid (99.99%) were acquired from Fisher 
Chemical (Fairlawn, NJ). Water was purified with a Nanopure Diamond water purifier 
(Barnstead International, Dubuqe, IA). (3-Amino)di-isopropylethoxysilane (APDIPES) was 
acquired from Gelest (Morrisville, PA). Bovine hemoglobin (Hb), pepsin enzyme, 
cyanoborohydride coupling buffer, sodium phosphate dibasic, trichloro(1H,1H,2H,2H-
perfluorooctyl)silane, and deuterium oxide (99.9%) were acquired from Sigma-Aldrich (St. 
Louis, MO). AL-20 POROS beads were purchased from Applied Biosystems (Carlsbad, CA). 
N-hydroxylsuccinimide functionalized polyethylene glycol (NHS-PEG) with 450 polymer 
units (MW = 20 kDa) was purchased from Nanocs, Inc. (Boston, MA). Human [Glu1] 
fibrinopeptide was purchased from American Peptide Company (Sunnyvale, CA). 
Phosphorylase b, Rpn1, and Ubp6 proteins were provided by the Engen laboratory at 
Northeastern University (Boston, MA). 
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3.2.2 Microchip Design and Fabrication 
A schematic of the CE-ESI microchip used in this work is shown in Figure 1. As 
described previously for CE-ESI,31,26 the microchip contains an injection cross, a separation 
channel, an electroosmotic pump, and an ESI emitter. The reservoir labels correspond to 
sample (S), background electrolyte (B), sample waste (W), and electroosmotic pump (EO). 
The length of the separation, EO pump, sample, background electrolyte, and sample waste 
channels were: 10 cm, 2.5 cm, 1 cm, 0.8 cm, and 0.8 cm, respectively.  
!!
Figure 3.1. Schematic of CE-ESI Microchip.  The reservoir labels correspond to sample (S), 
background electrolyte (B), sample waste (W), and electroosmotic pump (EO). The separation 
channel measures 10 cm long. The dimensions of the chip are approximately 3 cm wide by 6 cm long. 
For the complex mixture separation, the design was similar except the separation 
channel was 23 cm long while the EO pump channel was 3 cm long. Microchips were 
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fabricated using 0.5 mm thick B270 glass obtained from Perkin Elmer (Waltham, MA). 
Microchips were fabricated in house using previously described photolithography, wet 
chemical etching, and thermal bonding techniques.26 All channels were etched to 10 µm deep 
and 70 µm wide. Glass cylinders, 8 mm in diameter, were attached to the devices with a 
chemically resistant epoxy to serve as solvent reservoirs (Loctite E-120HP, Henkel 
Corporation, Germany).  
3.2.3 Microchip Surface Coating 
Microchips were coated with APDIPES in the gas phase using a commercially 
available Labkote chemical vapor deposition (CVD) system (Yield Engineering Systems, 
Livermore, CA) as described previously.27 Briefly, microchips were placed inside the 
vacuum chamber of the CVD system.  The coating protocol involved dehydration of the 
vacuum chamber, injection and vaporization of the silane reagent, a soak period where 
microchips were exposed to vaporized silane, and evacuation purges to remove reagent 
vapors. This protocol was repeated three times for a total coating time of 1 hour before 
removing the device from the CVD system. Following CVD coating, microchips were cooled 
to room temperature before further surface modification.  
After coating the microchips with APDIPES, the sample, background electrolyte, 
sample waste, and separation channels were modified with a PEG reagent in the liquid phase 
as described previously.32 An NHS-PEG solution was prepared in 100 mM phosphate buffer 
(pH 7.5) at a concentration of 5 mg/mL and flowed through the specified channels for a 
period of 1 hour. During PEGylation, the S, B, and W reservoirs were filled with PEG 
reagent and a head pressure of 25 psi was applied to each reservoir. The EO pump reservoir 
! 60!
was filled with background electrolyte (BGE) with vacuum applied at the ESI tip (Figure 3.1). 
PEGylated channels were subsequently rinsed with DI water for 10 min followed by BGE for 
10 min. After rinsing the device, the external surface of the ESI emitter was coated with 
trichloro-(1H,1H,2H,2H-perfluorooctyl)-silane to increase the surface hydrophobicity and 
facilitate ESI. 
3.2.4 Hydrogen Deuterium Exchange Sample Preparation and Workflow 
For HX MS, a stock of intact bovine hemoglobin was prepared in 20 mM TRIS buffer, 
H2O, pH 7.5. For CE-ESI, the stock concentration was 120 mg/mL while for LC-MS, the 
stock concentration was 24 mg/mL. A 5 µL aliquot of the stock solution was diluted 20-fold 
in either 20 mM TRIS buffer, H2O, pH 7.5 (undeuterated control) or 20 mM TRIS buffer, 
D2O, pD 7.5. The intact bovine hemoglobin was exposed to the deuterated buffer for four 
different time points (10 s, 1 min, 10 min, and 60 min) and the deuteration reaction quenched 
by diluting an aliquot of the labeled protein 5-fold in ice cold 0.5% formic acid which 
lowered the solution pH to 2.5. The protein was immediately digested by placing the 
quenched protein solution onto a Spin-X 0.22 µm centrifuge tube filter (Corning 
Incorporated, Corning, NY) loaded with 40 µL of pepsin bead slurry. Pepsin was 
immobilized via aldehyde coupling.33 The centrifuge tube was vortexed for 30 s at room 
temperature, and then the peptides were separated from the immobilized pepsin beads by 20 s 
of centrifugation at room temperature (CE) or 4 °C (LC).   
3.2.5 Microchip CE-ESI Operation 
Following sample preparation, the bovine hemoglobin peptide solution was mixed 1:1 
with acetonitrile and loaded into the sample reservoir of the CE-ESI microchip. Immediately 
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after loading the sample on the microchip, voltage was applied to the microchip. After 
waiting 15 s to ensure that the sample had reached the injection cross, the sample was 
injected onto the separation channel where the bovine hemoglobin digest underwent CE 
separation and detection via ESI-MS. The total time between quenching the deuteration 
reaction and injecting the sample onto the separation channel was between 100 and 110 s.  
CE-ESI microchips were operated by the application of voltages to the solvent 
reservoirs, as previously described.26,27 Home built reservoir caps containing platinum wire 
electrodes (Alpha Aesar, Ward Hill, MA) were used to form voltage connections to each 
reservoir. An in-house-built power supply was used containing five individual power supply 
modules from Ultravolt Inc. (Ronkonkoma, NY). Three of the modules (20A24-P15) 
supplied 0 to +20 KV while the other two modules (10A12-P4) could supply 0 to +10 KV. 
The power supply was controlled via an SCB-68 breakout box connected to a PC via a PCI 
6713 DAQ card. A LabVIEW program was used to control the voltage outputs. During 
microchip operation, voltages of +20, +20, +18, and +1 kV were applied to the S, B, W, and 
EO reservoirs, respectively. The applied voltages resulted in a field strength of 1500 V/cm in 
the separation channel. These conditions yielded a flow rate of approximately 630 nL/min 
exiting the ESI emitter of the microchip. To inject sample into the separation channel, the 
applied voltages were changed to +20, +19, +19, +1 kV at the S, B, W, and EO reservoirs, 
respectively. The length of the injection was 0.3 s. The background electrolyte for all CE 
separations was comprised of 50% acetonitrile, 0.5% formic acid, 49.5% water, pH 2.5. Ten 
nM glu-fibrinopeptide in BGE was placed in the EO pump reservoir to serve as a lock-mass 
reference compound (785.852+ ion). Lock-mass spectra were acquired before and after each 1 
min CE separation. The lock-mass scan time was 1 second with an interval of 70 s. Lock-
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mass data were acquired but not applied in real time; 3 scans were averaged with a mass 
window of ± 0.5 Da.    
The CE-ESI device was mounted on a custom built stage with the ESI corner 5 mm 
from the sample cone inlet of a Synapt G2 mass spectrometer (Waters Corporation, Milford, 
MA). A copper clad circuit board with 0.5 kV applied to it was used to shield the ESI emitter 
from the voltages applied to the microfluidic device as described previously.27 The 
instrument was run in resolution mode, with a summed scan time of 50 ms and an interscan 
delay of 24 ms. For the undeuterated controls, data-independent MS/MS was used to 
fragment and identify the peptides utilizing the Waters MSE function. In MSE, the collision 
cell rapidly switches between low and high collision cell energy, producing alternate 
precursor and fragment ion information.34 The low collision energy precursor scans had a 
trap energy equal to 6 V while the high-energy fragmentation scans had a trap energy of 32 V. 
MSE data were acquired from 50 – 1200 m/z. For the labeled time points, MS only data were 
acquired from 300 – 1200 m/z. 
3.2.6 LC-MS Operation 
LC-MS Hb deuterium exchange samples were prepared in a similar manner as those 
for CE-ESI, however the stock Hb concentration was reduced to 24 mg/mL. To minimize 
carryover, the pepsin digest was diluted 1:1 with 1:4 20 mM TRIS:0.5% formic acid solution 
prior to injection. The sample (50 µL) was injected into a Waters M-class nanoACQUITY 
UPLC with HX MS technology. The total time from quenching the labeling reaction and 
injection onto the instrument was 75 s. Peptides were trapped and desalted for 3 min at 100 
µL/min using a Waters VanGuard BEH C18 1.7 µm trap column. Chromatographic 
separation was performed using a 1 x 50 mm Waters ACQUITY UPLC C18 (HSS T3) 
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reversed-phase column at 0 °C. Peptides were eluted over 3 min with a linear 5-35% 
acetonitrile gradient at 100 µL/min. Mass spectra were obtained using a Waters Synapt G2Si 
operating in positive ion mode at a capillary voltage of 3 kV and a desolvation temperature of 
175 °C. For MSE, the low collision energy precursor scans had a trap energy of 4 V and high 
energy fragmentation scans had a trap energy of 32 V. The instrument was run with a 
summed scan time of 200 ms and an interscan delay of 24 ms. Human Glu-fibrinopeptide 
was infused at 5 µL/min through the reference probe and scanned every 10 s, with the 
785.852+ ion used as a lockmass.  
3.2.7 Complex Mixture Sample Preparation and Separation 
A mixture containing 48 pmol phosphorylase b, 95 pmol Rpn1, and 82 pmol Ubp6 in 
20 mM Tris was mixed 1:1 with 0.8 M guanidine hydrochloride, 0.8% formic acid. Digestion 
was initiated via addition of 7.5 µL immobilized pepsin, and proceeded for 5 min on ice. 
Resultant peptides were isolated by filtering through a Spin-X 0.22 µm centrifuge tube filter 
(Corning Incorporated, Corning, NY), centrifuged at 7800 g for 30 s. For LC-MS, the sample 
was analyzed in a similar manner to the Hb samples, however peptides were eluted from a 1 
x 100 mm Waters ACQUITY UPLC C18 (BEH) column using a linear 5-40% acetonitrile 
gradient over 9 min. 
For CE-ESI, following digestion, the mixture sample was concentrated and desalted 
using an Oasis HLB solid phase extraction cartridge (Waters Corporation, Milford, MA). The 
cartridge was loaded with 300 µL of 3 µM digest material, washed with 500 µL of 0.5% 
formic acid, and eluted with 100 µL of 90% acetonitrile, 0.05% formic acid. The sample was 
separated using a 23 cm CE-ESI microchip. The chip operation was identical to that already 
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described with the following exceptions: The BGE was 50% acetonitrile, 1% formic acid. 
Voltages of +22, +22, +20, and +1.5 kV were applied to the S, B, W, and EO reservoirs, 
respectively, resulting in a field strength of 767 V/cm in the separation channel. To inject 
sample into the separation channel, the applied voltages were changed to +22, +21, +21, +1.5. 
The length of the injection was 0.8 s.  The Synapt G2 was run in resolution mode with a 
summed scan time of 100 ms with an m/z range of 300 - 1200.  
3.2.8 Data Processing 
The software program Peakfinder (downloaded from Pacific Northwest National Lab) 
was used to calculate the separation window, median 4σ peak width, and peak capacity for 
all separations. Peptides from both CE and LC experiments were identified using 
ProteinLynx Global Server (PLGS) 3.0 and deuterium incorporation was calculated with 
DynamX 2.0 software. The following parameters were utilized by DynamX to filter the 
PLGS output data prior to calculating deuterium uptake, protein sequence coverage, and 
peptide redundancy: 0.3 products per amino acid, 3 consecutive products, 10 ppm mass error 
on parent ion, identified in all undeuterated control runs.  
3.3 Results and Disucssion 
3.3.1 CE-ESI Separation Performance 
To demonstrate the validity of CE-ESI for separations under conditions that would be found 
in a hydrogen exchange mass spectrometry experiment, CE-ESI microchips were used to 
analyze a pepsin digest of bovine hemoglobin. The microchips utilized a surface coating and 
chip operation scheme recently described for intact protein separations;32 this is the first 
report of using these chips for analyzing peptide digests. The surface coating reduces the 
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electroosmotic flow in the separation channel to near zero; the movement of analytes is 
primarily due to electrophoretic migration. Figure 3.2 compares a microchip CE-ESI-MS 
electropherogram of a bovine hemoglobin pepsin digest to the LC-MS separation of the same 
sample using a state-of-the-art UPLC system for HX MS experiments, the Waters M-Class. 
As demonstrated by the figure, the CE separation of the hemoglobin digest, which took place 
at room temperature, is very fast and completed in less than 1 min. Run-to-run 
reproducibility was high.  Three replicate injections of the hemoglobin digest were utilized to 
assess the run-to-run migration time reproducibility. For three representative peptides 
spanning the window of the electropherogram (m/z values of 429.3, 590.6, and 660.9 with 
migration times of 52, 31, and 21 s, respectively), the migration time relative standard 
deviation (RSD) was calculated to be 0.75%. The observed median width at base for the 
peaks in CE (n = 29) was 0.61 s, corresponding to a peak capacity of 62. For such a rapid 
separation, this represents an extremely high peak capacity. The metric of peak capacity/min 
represents how quickly a separation technique can generate resolving power. After 
accounting for the time between sample loading and injection on the microchip, the 
hemoglobin digest CE-ESI separation has a calculated peak capacity/min of 53.4. In 
comparison, Busnel et. al. utilized a sheathless porous tip to perform CE-ESI of protein 
digests and in a 60 min separation, a peak capacity of 193 was reported (using 4σ peak 
width), corresponding to a peak capacity/min of 3.2.35 By contrast, a typical LC separation 
peak capacity generally ranges from 100 – 400, but can take several hours to achieve these 
results, yielding peak capacity/min values in the range of 1.5 – 3.9.36,18  
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Figure 3.2. CE-MS (top) versus LC-MS (bottom) of the same bovine hemoglobin pepsin digest.  CE-
ESI was performed at room temperature while LC-MS was performed at 0 °C.  
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To assess the separation performance of the CE-ESI microchip relative to the current 
paradigm for HX MS experiments, we compared the microchip CE separation at room 
temperature to a UPLC separation performed at 0 °C of the same bovine hemoglobin digest. 
As illustrated by Figure 3.2, the LC separation run time is just under 4 min. After adding the 
3 min trapping time prior to the LC separation, the time between sample loading and 
detection is 7 min for the last eluting species in the LC run. The observed peak capacity of 
the chromatogram was 31 with a median peak width (n = 16) of 5.35 s. For the hemoglobin 
digest sample, the LC chromatogram has a peak capacity/min of 4.4. This comparison 
highlights the speed and resolving power of microchip CE compared to LC; the peak 
capacity/min of the CE electropherogram is more than an order of magnitude greater than the 
LC separation.  Table 3.1 compares figures of merit for the CE-ESI and LC-MS methods, 
highlighting differences in speed, peak width, and separation performance. The table further 
illustrates the improved performance coupled with faster run times, demonstrating the 
potential for utilizing CE-ESI for HX MS experiments.  We note that in one of the early 
reports14 of the fragment separation method for HX analysis of hemoglobin, then detected by 
scintillation counting, the HPLC run time was in excess of 90 min. The microchip CE-ESI 
separation time described in this work is 100-times faster.   
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Table 3.1. Comparison of CE and LC figures of merit for bovine 
hemoglobin pepsin digest separation 
Characteristic LC CE 
  
Separation speed (min) 3-12 1-4 
Peak width (s) 5-10 <1 
Injection amount (fmol) ~50000 ~5 
Flow rate (µL/min) 50-100  <1 
Hb peak capacity/min 4.4 62 
Retention/Migration time 
%RSD 0.4 1.1 
Commercial availability 
Waters M-Class 
UPLC with HDX 
Technology 
None 
MS modifications required None Moderate source changes 
 
 3.3.2 MS Performance 
Data-independent MS/MS (MSE) of a hemoglobin pepsin digest was performed to 
identify the peptic peptides separated by fast CE-ESI.  To the best of our knowledge, this 
work represents the fastest ever utilization of MSE. In 2010, Bonn et al. reported LC-MSE of 
metabolites with a summed scan time of 100 ms.37 In this manuscript, the summed scan 
speed was 50 ms, sampling twice as fast. Figure 3.3 shows representative peaks from both 
the microchip CE-ESI electropherogram and the LC-MS chromatogram, illustrating the 
number of MS data points across each peak. For the CE separation, a summed scan time of 
50 ms and an interscan delay of 24 ms correspond to a data acquisition rate of approximately 
13.5 Hz. 
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Figure 3.3. Representative peak profiles from bovine hemoglobin pepsin digest showing data points 
across peak for CE (top) and LC (bottom). 
While performing the MSE function, data points are alternated between low and high 
collision energy; therefore, for each scan, the MS sampling rate decreases to roughly 6 Hz 
per trace. Given the average peak width at base in the electropherogram of 0.61 s, the 
average CE peak will have 3.8 data points per peak at each collision energy. As a comparison, 
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the average LC peak from the hemoglobin chromatogram will have 12 data points per peak at 
each collision energy. This indicates one of the challenges associated with coupling high 
speed separations to MS. Although mass spectrometers have improved greatly over the past 
decades, coupling to extremely fast separations remains challenging, and often mass 
spectrometers struggle to maintain adequate sampling of narrow microchip CE peaks.38 The 
3.8 data points per peak results in peak undersampling, artificially broadening the reported 
peak widths. Therefore, a faster acquisition rate would perhaps reveal even greater separation 
performance than that reported here. While there is concern that the observed peak 
undersampling would diminish the ability to identify peptides with MSE, the preliminary 
results from this work seem to indicate that this is not the case. The data could still be 
processed by commercially available software to identify peptides in the electropherogram. 
Accurate mass measurements are crucial for reliable peptide identification.39 For ESI, 
this is most often accomplished utilizing internal calibration from a reference compound, or 
‘lock-mass’.40 There are multiple ways of introducing the lock-mass compound into the mass 
spectrometer. Typically, the lock-mass compound is either introduced post-column at a ‘T’ 
junction,41 which can introduce band broadening to the separation, or multiple emitters are 
utilized,42 introducing instrumental complexity and data sampling concerns.43 Another 
strategy is to mix the reference compound directly with the mobile phase of an LC separation, 
however, interaction with the stationary phase can limit the choice of an acceptable lock-
mass compound and may have implications on the separation performance. Microchip CE-
ESI offers a unique solution to this problem. We simply added a very low concentration (10 
nM) of a lock-mass compound (glu-fibrinopeptide B) to the BGE in the EO pump reservoir 
of the microchip. Based on the applied voltages, fluid from the EO pump reservoir flows 
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towards the ESI emitter, comprising the bulk fluid flow necessary for ESI generation. Lock-
mass spectra were acquired at the beginning of each CE-ESI electropherogram. The short CE 
analysis time eliminates the need to make further lock-mass acquisitions.  This strategy 
avoids both band-broadening and data sampling concerns and is a much simpler solution than 
using dual emitters. This approach is only possible using the described microchip CE-ESI 
platform, and would not be amenable for use with an LC-MS system. Using this strategy, we 
observed a mass error of less than 5 ppm for the identified peptide parent ions. In the absence 
of the lock-mass compound, a mass error of near 50 ppm was typically observed. 
3.3.3 Sequence Coverage and Limitations 
For HX MS experiments aimed at analyzing intact proteins or protein complexes, 
maximizing the structural information contained in the peptide digest data is paramount. 
Protein sequence coverage and peptide redundancy are important metrics when evaluating 
MS data for HX MS. Following peptide identification with PLGS, the data were filtered with 
DynamX prior to calculating sequence coverage and peptide redundancy. For the microchip 
CE-ESI separation of bovine hemoglobin pepsin digest, the sequence coverage of the α and β 
chain was 48.2% and 84.8% with a redundancy score of 3.29 and 1.29, respectively. For the 
LC-MS method, the sequence coverage was 97.9% and 92.4% with redundancy scores of 
6.62 and 5.20. While initially concerned that the mass accuracy may be contributing to the 
poor sequence coverage, analysis of the data revealed that the mass accuracy was quite 
comparable between the two methods.  The average mass error for the CE and LC methods 
was ± 1.5 ppm and ± 3.0 ppm respectively for identified peptides.  While the data shown here 
indicate that microchip CE-ESI has less than ideal sequence coverage, low coverage at this 
early stage of development should not detract from the potential of utilizing high speed CE 
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separations for HX MS.  The decreased sequence coverage and redundancy scores are likely 
the result of the several factors discussed below, including changes to separation speed, 
sensitivity, injection volume and preconcentration. Many of these aspects can be addressed in 
future method development.  
Separation Speed.  Increasing the speed of separation while maintaining, or 
enhancing, separation performance necessitates short duration peaks. As discussed earlier, 
the average peak width of the CE separation is roughly an order of magnitude narrower than 
the LC peaks (0.6 s v 5.35 s). If all else were equal, this would adversely affect the sensitivity 
of the CE method as the mass spectrometer has approximately one-tenth the time to acquire 
spectra. Furthermore, in certain cases the narrow peak width may have diminished the ability 
of the PLGS software to identify the peaks regardless of their concentration. While many 
more peptides were identified with the LC-MS method, certain peptides of corresponding 
m/z and charge state were also observed in the CE method, but were not positively identified 
by the software. In most cases, these peptides were above the intensity thresholds set for 
PLGS, therefore, we attribute the missing data to the narrow peak widths. 
Sensitivity. The LC data used for comparison were acquired using a more sensitive 
mass spectrometer (Synapt G2Si) than the CE data (Synapt G2), a difference easily remedied. 
The difference in mass spectrometer scan speed (200 ms scan time for the LC v. 50 ms for 
the CE) between the two methods exacerbates the sensitivity variation between the two mass 
spectrometers. 
Injection volume. In order to perform an extremely rapid, high peak capacity 
separation, the injection volume must be as low as possible in order to minimize the injection 
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broadening contribution to the peak width. For the microchip CE separation, the injection 
volume was 600 pL, compared to the 50 µL injected onto the LC column. The difference in 
initial protein concentration was done intentionally to partially offset the difference in 
injection volume; however, when comparing amount injected, the LC method used 17,000 
times more sample than the CE method. For the initial protein stock concentration of 120 
mg/mL, the amount of sample injected onto the CE separation capillary was approximately 
350 pg. For the LC method, an initial protein stock concentration of 24 mg/mL corresponded 
to 6 µg injected on column, more than 4 orders of magnitude greater than the amount utilized 
for the CE method.  
Preconcentration. LC-MS as implemented for this comparison has a significant 
advantage in that there is an integrated sample pre-concentration step resulting from the use 
of a trap column. By loading a large volume of sample and concentrating at the head of the 
LC column, a significant increase in peak concentration can be observed. Unfortunately, this 
type of sample processing is more difficult to integrate with CE-ESI and was not done in the 
current comparison. Although a significant focus in the literature, a robust method for 
coupling sample processing with CE-ESI remains challenging.44,45 For the LC method, 
concentrating a large sample at the head of the column and eluting a narrow injection band 
resulted in a peak concentration increase, boosting sensitivity. The injection volume of the 
LC sample was 50 µL; the average peak volume at detection was 8.9 µL, resulting in a 5.6-
fold peak concentration. Conversely, the injection volume of the CE separation was 600 pL, 
while the average peak volume at detection was 1.15 nL, resulting in a nearly 2-fold dilution. 
Integrated sample processing on-chip would potentially eliminate the sample 
preconcentration limitations of the microchip CE-ESI system described here, thereby 
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removing the sensitivity issues and peptide coverage difficulties apparent in this initial 
comparison. Furthermore, integrating sample processing onto the CE-ESI microchip will 
likely improve the compatibility of the method with the high concentration of salt, reducing 
agents, and denaturants commonly employed in HX MS workflows. Work describing the 
design and optimization of integrated sample processing will be the focus of a subsequent 
chapter.  
3.3.4 Deuterium Recovery 
Deuterium recovery must be addressed in any new HX MS method. After 
demonstrating the separation power and MS performance of the CE-ESI microchip with 
undeuterated protein, a deuterium labeling experiment of the bovine hemoglobin digest was 
performed to compare deuterium uptake between the CE and LC methods. Peaks between the 
control and deuterated time points were matched based on either retention or migration time, 
underscoring the need for an extremely reproducible separation. Over the course of the 
labeling experiment, the CE method had a migration time reproducibility of 1.14 RSD. For 
the LC separations, the RSD for retention time was 0.38%. Unlike the LC method, the CE 
separation was not temperature controlled, which may have contributed to the observed 
migration time variance. Despite the extremely narrow CE peaks, the commercial Waters HX 
software (DynamX) was capable of matching peaks between the undeuterated control run 
and the labeled time points in order to quantify the changes in deuterium uptake.    
Figure 3.4 illustrates the comparison of deuterium uptake between CE and LC for 6 
hemoglobin peptides, 3 from the α chain and 3 from the β chain. Note that the separations 
occurred at different temperatures: the CE separation was performed at room temperature 
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while the LC separation was performed at 0 °C. 
 
Figure 3.4. Measured deuterium level comparison for six representative peptic peptides from bovine 
hemoglobin.  Error bars, representing standard deviation of duplicate measurements, are present but 
in most cases too small to see. 
Decreasing the temperature to 0 °C will reduce the rate of H/D back exchange 
approximately 10-fold versus room temperature.46 Given this difference in temperature, we 
would expect the CE method to result in roughly 10 times more deuterium loss (because it 
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was done at higher temperature) than the LC method. However, the CE method was faster 
overall, reducing the time available for back exchange. We define the time window for back 
exchange as the time between quenching the deuterium labeling reaction and completing the 
separation. For the CE method, the time window for back exchange was 2.5 min (1 min 
separation plus 1.5 min of digestion and sample preparation). For the LC separation, the time 
window was 8.5 min (4 min separation, 3 min of trapping, 1.5 min of digestion and sample 
prep). Weighing the differences in time and temperature between CE and LC, the amount of 
deuterium should be similar,46 as Figure 3.4 confirms.  Three peptides (α107-141, β13-29, 
and β125-144) displayed nearly identical deuterium uptake, α1-29 retained more deuterium 
using the LC method, and α107-125 and β113-124 slightly more deuterium using the CE 
method. These small differences were reconciled by accounting for experimental temperature 
and peptide elution time.46  
3.3.5 Complex Mixture Analysis 
The analysis of protein complexes and complicated systems serves as one of the 
primary reasons for pushing microchip CE-ESI forward as a method for HX MS. In order to 
demonstrate the improved speed and separation power of CE-ESI, a complex mixture of 270 
kDa was separated using both CE-ESI and LC-MS. Figure 3.5 illustrates the 
electropherogram (top) and chromatogram (bottom) of the sample. As illustrated by the 
figure, the CE separation is much faster and efficient compared to the LC separation. The CE 
run time is around 4 min, while the LC run time is near 10 min. For the CE electropherogram, 
the observed median peak width was 0.79 s (n = 36), resulting in a peak capacity of 195. For 
the LC chromatogram, the median peak width was 7.6 s (n = 47), resulting in an observed 
peak capacity of 77. This comparison illustrates the potential for CE-ESI as a platform for 
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HX MS experiments; the CE separation is over 2 times faster with more than double the peak 
capacity for a protein complex mixture.  
 
Figure 3.5. Comparison of CE-ESI electropherogram (top) and LC-MS chromatogram (bottom) of 
270 kDa complex mixture separation.  
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3.4 Conclusions 
In this report, we have demonstrated that microchip CE-ESI is fast, reproducible, and 
offers increased resolving power for HX MS experiments. Microchip CE-ESI of a bovine 
hemoglobin pepsin digest resulted in vastly superior peak capacity (62 in less than 60 s) 
compared to a state of the art UPLC separation of the same sample (peak capacity of 31 in 7 
min). Faster separation means higher deuterium recovery, all with improved separative 
performance. These innovations are possible due to implementing the CE-ESI monolithically 
on a microchip. In the simple tests shown here, the CE method observed similar amounts of 
deuterium uptake when compared against the LC method even though the temperature and 
time parameters were different. Future reports will describe both the operation of microchip 
CE-ESI at low temperatures as well as integrating digestion and sample processing directly 
on a microchip to further minimize experiment processing time and back exchange and 
increase automation. An additional benefit of integrating these functionalities onto a single 
microchip could be to reduce the overall sample consumption, which could provide a 
significant advantage in a sample limited setting. While the sequence coverage for the CE 
method left room for improvement, the results were attributed to the speed of the CE 
separation and the decreased sensitivity when compared to the LC method. Integrating pre-
concentration and sample processing with microchip CE-ESI will be critical in improving the 
sensitivity of the method in order to increase the observed sequence coverage.  The improved 
separation performance for complex mixtures was clear in the CE-ESI method; not only was 
the separation faster, but the peak capacity was higher.  Even more complex systems could 
therefore be within reach, including large protein machines and systems.  Overall, we believe 
that microchip CE-ESI presents a promising platform for HX MS. A fully integrated and 
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automated CE-ESI microchip could provide a very powerful tool for the HX MS analysis of 
complex mixtures, greatly expanding the scope of biological systems that can currently be 
analyzed.  
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CHAPTER 4: LOW TEMPERATURE MICROCHIP CAPILLARY-
ELECTROPHORESIS ELECTROSPRAY-IONIZATION 
4.1 Introduction 
Temperature plays an important role in the performance of liquid phase separation 
methods. High performance liquid chromatography (HPLC) is often operated using 
conditions above ambient temperature to realize gains in speed and efficiency, ranging from 
a few degrees above room temperature to well above 100 °C.1-3 Increasing the temperature 
lowers the mobile phase viscosity, resulting in lower backpressure yielding faster run times 
or enabling the use of longer columns. Higher temperatures also raise analyte diffusivity, 
resulting in decreased resistance to mass transfer and improved column efficiency.1 
Furthermore, modifying the temperature can alter the selectivity of a column, assisting in the 
optimization of the separation.4 High temperature LC has been utilized to improve the 
separation of numerous analytes, including small molecules, polymers, peptides, and 
proteins.1,4-7 However, not all applications are amenable to the use of high temperatures, 
notably hydrogen exchange mass spectrometry.  
Hydrogen exchange mass spectrometry (HX MS) is a powerful tool for investigating 
the conformation and dynamics of intact proteins.8 The strategy for HX MS consists of 
labeling intact proteins with deuterium; hydrogen molecules on the protein backbone 
exchange with deuterium present in solution and the amount of hydrogen/deuterium 
exchange yields information regarding the folded structure of the protein.9 The deuterium 
uptake is quantified by observing the mass shift between an undeuterated peptide and a 
peptide exposed to deuterium.10 The current paradigm of HX MS relies on LC separations 
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performed at low temperatures with fast gradient times in order to minimize 
hydrogen/deuterium back-exchange. However, because the efficiency of LC is limited by the 
resistance to mass transfer (the van Deemter C-term), under these conditions there is a 
fundamental plateau of separation performance. Even state of the art Ultra Performance 
Liquid Chromatography (UPLC) cannot exceed a peak capacity much greater than 60 under 
these conditions.11 This separation performance makes investigating large protein complexes 
with HX MS challenging, and potentially limits the utility of the technique for studying 
biological processes.  
Capillary zone electrophoresis coupled with electrospray ionization (CE-ESI) is an 
attractive candidate for HX MS based on the high speed and efficiency of the technique. 
Furthermore, according to CE theory, the efficiency of a separation should improve as the 
temperature is lowered, as seen in Equation 1, where q is the charge, V is the applied voltage, 
and k is the Boltzmann constant.12  
                                                                           
                                        (1) 
While work focusing on the effect of temperature on separation performance is 
common for HPLC, there are relatively few studies focusing on temperature effects in CE. It 
is generally accepted that lowering the temperature of a CE separation can improve the 
resolution; however, most manuscripts have not taken a fundamental approach to quantifying 
the improvements in efficiency as a function of temperature. To our knowledge, the only 
manuscript to investigate the theory and performance of CE as a function of temperature was 
published in 1998 by Ma and Horváth, and no investigation has been published to date 
coupling low temperature CE with MS detection. Previous studies have used subambient CE 
N = qV2kT
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to probe cis/trans conformers of various peptides; lowering the temperature increased the 
relaxation time between each species to longer than the run time and improved resolution.13-
16 Low temperature CE has also been used for the separation of enantiomers using chiral 
additives; lowering the temperature can improve complex formation between the analyte and 
the additive, resulting in improved resolution.17-21 Chen et. al. coupled low temperature CE 
with non-line narrowing spectroscopy performed at 77 K.22 Finally, it was demonstrated that 
lowering the temperature of CE could permit the use of higher ionic strength buffers and 
larger inner diameter (i.d.) columns.12,23  
Previously in our laboratory we have demonstrated a fully integrated microchip CE-
ESI method that was found to be very fast, efficient, and highly reproducible.24-27 A recent 
publication in our laboratory investigated the potential utility of microchip CE-ESI for HX 
MS.28  The high speed and efficiency of the technique demonstrated the potential of using 
CE-ESI for HX MS; however, the performance of our microchips at low temperatures was 
not explored. In this work, the fundamental performance of microchip CE-ESI at 
temperatures between ambient and 0 °C was investigated and builds upon previous work 
demonstrating the potential utility of microchip CE-ESI for HX MS. Microchip CE-ESI-MS 
separations of a mixture of peptides at different temperatures with a constant applied voltage 
were performed. The efficiency of each peptide was measured as a function of temperature 
and the observed results were compared to theory. Separations at varying temperatures and 
field strengths to investigate the relationship between temperature, separation run time, and 
efficiency were also performed. ESI infusion data were acquired to investigate the 
performance of ESI as the temperature decreased and compared to separation 
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electropherograms. Finally, a hydrogen/deuterium back-exchange experiment was performed 
in order to demonstrate the effect of temperature on deuterium retention.       
4.2 Experimental 
4.2.1 Reagents and Materials 
LC-MS grade methanol, acetonitrile, and formic acid (99.99%) were acquired from 
Fisher Chemical (Fairlawn, NJ). Water was purified with a Nanopure Diamond water purifier 
(Barnstead International, Dubuque, IA). (3-Amino)di-isopropylethoxysilane (APDIPES) was 
acquired from Gelest (Morrisville, PA).  Sodium phosphate dibasic, trichloro(1H,1H,2H,2H-
perfluorooctyl)silane, and deuterium oxide (99.9%) were acquired from Sigma-Aldrich (St. 
Louis, MO). N-hydroxylsuccinimide functionalized polyethylene glycol (NHS-PEG) reagent 
with 450 polymer units (MW = 20 kDa) was purchased from Nanocs, Inc. (Boston, MA). 
Met-enkephalin, bradykinin, angiotensin II, and thymopentin were purchased from American 
Peptide Company (Sunnyvale, CA).  
4.2.2 Microchip Design, Fabrication, and Surface Coating 
A CE-ESI microchip with a 10 cm separation channel was used in this work and is 
similar to previously published designs, with a channel depth of 10 µm and a full width of 70 
µm.25,26 A schematic of the microchip can be seen in Figure 4.1. The microchip was 
fabricated out of 550 µm thick D263 glass using standard photolithography, wet chemical 
etching, and thermal bonding techniques.25,26 The microchip was then coated with APDIPES 
and modified with an NHS-PEG reagent as described previously.24,27  
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Figure 4.1. Microchip CE-ESI schematic. Reservoirs correspond to sample (S), background 
electrolyte (B), waste (W), and electroosmotic pump (EO). ESI denotes the electrospray emitter. 
Dashed line corresponds to the border of the Peltier thermoelectric device. 
4.2.3 Peltier Cooling Device 
A block diagram of the Peltier cooling device can be seen in Figure 4.2. The dotted 
black line represents the orientation of the microchip in relation to the Peltier device. The 
temperature of the microchip was controlled using a 2” square Peltier device. The Peltier 
cooling device was mated to an aluminum water block acting as a heat sink; both were 
purchased from Custom Thermoelectric (Bishopville, MD). Ice-cold water was pumped 
through the water block using a PolyScience model 8010 circulator (MG Scientific, Pleasant 
Prairie, WI).  
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 Figure 4.2. Instrumental setup for the Peltier cooling device. The dotted black line corresponds to the 
relationship between the microchip and the Peltier. ESI and MS correspond to electrospray emitter 
and mass spectrometer, respectively. Drawing not to scale; however, the relationship in size between 
the chip, Peltier, and water block is accurate.   
The surface of the Peltier was first covered with a pyrolytic graphite sheet (Panasonic, 
Newark, NJ) to ensure an even temperature distribution across the surface of the device. The 
pyrolytic graphite sheet was then covered with conductive copper tape (Fisher Scientific, 
Pittsburgh, PA) that was attached to electrical ground to prevent electric damage to the 
temperature-controlling unit in the event of arcing between the high voltage electrodes. The 
temperature of the Peltier device was controlled using a MPT5000 temperature controller 
(Wavelength Electronics, Bozeman, MT). The MPT5000 was connected to a 5-amp direct 
current power supply (BK Precision, Yorba Linda, CA) and two digital multimeters (Fluke, 
Everett, WA). Two thin film RTD probes (Omega Engineering, Stamford, CT) were placed 
! 89!
on the surface of the Peltier. One RTD probe provided temperature feedback for the 
MPT5000 while the other was connected to an Agilent 34411A digital multimeter to visually 
display the temperature (Agilent, Santa Clara, CA). The accuracy of the temperature readout 
was evaluated by measuring the resistance of the RTD sensor at a given temperature and 
comparing to known literature values provided by the manufacturer of the RTD. Good 
agreement was observed between the measured resistance value and the literature value 
indicating an accurate temperature measurement (data not shown). The RTD sensors were 
glued to the surface of the Peltier using arctic alumina thermal epoxy (Custom 
Thermoelectric). Condensation may be an issue when performing low temperature microchip 
CE-ESI. While condensation was not a factor during the experiments described in this 
manuscript, reproducing this work may require performing microchip CE-ESI in a dry 
environment. This could be achieved by encapsulating the microchip in an airtight enclosure 
and changing the environment to a dry gas, or other methods of humidity control could be 
sufficient.   
 
4.2.4 Microchip CE-ESI Operation!
CE-ESI microchips were operated by the application of voltages to the solvent 
reservoirs, as previously described.24,27 In-house built reservoir caps containing platinum 
wire electrodes (Alpha Aesar, Ward Hill, MA) were used to form voltage connections to each 
reservoir. An in-house-built power supply was used containing five individual power supply 
modules from Ultravolt Inc. (Ronkonkoma, NY). Three of the modules (20A24-P15) 
supplied 0 to +20 KV while the other two modules (10A12-P4) could supply 0 to +10 KV. 
The power supply was controlled via an SCB-68 breakout box connected to a PC via a PCI 
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6713 DAQ card (National Instruments, Austin, TX). A LabVIEW program was used to 
control the voltage outputs. 
The CE-ESI device was mounted on a custom built stage fitted with a Peltier device. 
The ESI corner was 5 mm from the sample cone inlet of a LCT Premier time of flight mass 
spectrometer (Waters Corporation, Milford, MA). A copper clad circuit board with 0.5 kV 
applied to it was used to shield the ESI emitter from the voltages applied to the microfluidic 
device as described previously.24,27 The instrument was operated in V mode, normal dynamic 
range with a summed scan time of 90 ms and a mass range of 330 – 600 m/z. Unless 
otherwise noted, the background electrolyte (BGE) for all CE separations was comprised of 
49% methanol, 2% formic acid, 49% water, pH 2.2.  
A vacuum pinch injection29 was used to introduce reproducibly small sample bands 
into the CE separation channel. For the pinch injection, vacuum was applied to the waste 
reservoir for 2 s in the absence of applied voltage. This resulted in a small plug of sample 
contained at the head of the separation capillary. Next, the vacuum was turned off while 
simultaneously applying voltage to all reservoirs of the chip, resulting in the injection and 
separation of the sample in the CE separation channel. The injection volume was estimated to 
be 35 pL. The vacuum was controlled using a 3-way electronic valve (Clippard, Inc., 
Cincinnati, OH), which was operated by the same breakout box and Labview program used 
to control the applied high voltages. Unless otherwise noted, voltages of +15, +13.5, +13.5, 
and +1.1 kV were applied to the S, B, W, and EO reservoirs, respectively. These applied 
voltages resulted in a field strength of 1050 V/cm. When the temperature of the microchip 
was changed during an experiment, the temperature of the microchip was equilibrated for 
two minutes (min) at each new temperature before proceeding. 
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4.2.5 Temperature Controlled Separations 
Separations of a 4-peptide mix were performed at 6 different temperatures using a 
vacuum pinch injection: 30 °C (no temperature control) and 20 through 0 °C in increments of 
5 °C. The applied voltage and injection volume was constant for all temperatures. A mix of 
50 µM met-enkephalin, angiotensin II, bradykinin, and thymopentin dissolved in BGE was 
placed in the sample reservoir, while the remainder of the reservoirs contained BGE. Next, 
separations of this mixture were performed at 25 °C and 0 °C. The applied voltages were 
altered at the two temperatures to keep the separation time constant. At 25 °C, the field 
strength was 792 V/cm; at 0 °C, the field strength was increased to 1475 V/cm.  
4.2.6 Stopped Flow  
Stopped flow experiments were performed at 30 °C and 10 °C to measure the 
diffusion coefficients of the four peptides in BGE. A mixture of the peptides was placed in 
the sample reservoir while the remainder of the microchip contained BGE. Sample was 
injected into the separation channel using a vacuum pinch, separated for 30 s, and then the 
applied voltages were turned off for between 10 and 300 s. The voltage was then reapplied 
and the separations were completed. Plotting the spatial variance versus time resulted in a 
slope equal to twice the diffusion coefficient, according to Equation 2.24 
                                                         (2) 
 
 
 
σ 2 = 2Dt
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4.2.7 Microchip CE-ESI Infusion 
500 nM fluorescein dissolved in BGE was placed in the EO pump reservoir and 
infused into the mass spectrometer. The rest of the reservoirs contained BGE. Infusion data 
were acquired for 30 seconds (s). The temperature was lowered from 30 °C (no temperature 
control) to 0 °C. Voltages of +15, +13.5, +13.5, and +1.1 kV were applied to the S, B, W, 
and EO reservoirs, respectively, resulting in a field strength of 1050 V/cm. Next, while the 
microchip was at 0 °C, the applied voltages were increased to +20, + 18.5, + 18.5, and + 1 
kV, resulting in a field strength of 1475 V/cm.  
4.2.8 Hydrogen/Deuterium Back Exchange 
A hydrogen/deuterium back exchange experiment was performed to observe the 
effect of temperature on deuterium retention. The BGE for this experiment was 49% 
acetonitrile, 49% water, and 2% formic acid, pH 2.2. First, a sample of three peptides 
(thymopentin, bradykinin, and angiotensin II) dissolved in aqueous BGE (49% acetonitrile, 
2% formic acid, 49% water) was separated at 25 °C and a field strength of 875 V/cm. Next, a 
sample of the peptide mixture was dissolved in deuterated BGE (49% acetonitrile, 2% formic 
acid, 49% deuterium) and incubated for 8 hours at 25 °C. After 8 hours, the peptides were 
fully deuterated; all exchangeable hydrogens on the peptide molecules had been replaced 
with deuterium. The fully deuterated peptide mix was placed in the sample reservoir of the 
microchip and separated using the same method as previous (25 °C, 875 V/cm). The 
microchip contained aqueous (non-deuterated) BGE; therefore, when the sample was injected 
into the separation channel, hydrogen/deuterium back exchange began to occur. The 
separation was repeated with the same applied voltage at 0 °C. Finally, the temperature was 
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lowered to 0 °C and the field strength was increased to 1475 V/cm. The electric field was 
adjusted between the two temperatures to keep the migration times constant for the run at 
25 °C and 0 °C, so temperature was the only variable affecting the exchange rate.    
4.2.9 Data Processing 
Extracted ion electropherograms were exported into the software program Igor Pro 
(Wavemetrics, Lake Oswego, Oregon). The analysis package multi-peak fit 2 was used to 
measure the full width, half maximum as well as the peak area for all peaks of the 
electropherogram. Relative deuterium uptake was calculated according to Weis et al.30 First, 
peptide spectra were centered in the software MassLynx (Water Corporation, Milford, MA). 
Next, the centroid mass of the spectra was determined using Equation 3, where I is the 
spectral intensity. Finally, relative deuterium uptake (R.D.U.) was calculated according to 
Equation 4, where m corresponds to the centroid mass under the given experimental 
condition and m0% corresponds to the centroid mass of the undeuterated peptide. 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! (m / z)i × Iii∑ Iii∑ !!! ! ! !!!!!!!! ! (3)!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!R.D.U .=m−m0% !!!!! ! !!!!!!!! ! !(4)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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4.3 Results and Discussion 
4.3.1 CE-ESI Separation Performance  
According to theory, the efficiency of a CE separation should increase linearly as the 
temperature decreases as long as the applied voltage remains constant. To investigate the 
separation performance of CE-ESI at low temperatures, a 4-peptide mix was separated at 
various temperatures ranging from 30 °C (no temperature control) to 0 °C. In the absence of 
active cooling, the temperature of the microchip stage was 30 °C, which is elevated above 
room temperature. This was due to the local environment near the inlet of the mass 
spectrometer. A vacuum pinch injection was utilized to ensure that the injection volume was 
small enough that injection broadening didn’t significantly contribute to peak widths. The 
injection volume was estimated to be 35 pL, over an order of magnitude smaller than typical 
injection volumes using our microchip CE-ESI devices.24-26 Due to the small injection 
volume, the concentration of the sample was increased to 50 µM to improve the signal/noise 
ratio of the peaks. Figure 4.3 illustrates electropherograms of six different temperature 
separations with the applied voltage kept constant. As the temperature decreased, the analyte 
migration times were observed to increase. At 30 °C, the migration time of the four peptides 
were as follows: thymopentin – 0.94 min, bradykinin – 1.09 min, angiotensin II – 1.18 min, 
and met-enkephalin – 2.67 min. At 0 °C, the migration times were 2.28, 2.66, 2.86, and 6.12 
min, respectively. This corresponds to a 2.4 fold increase in migration time as the 
temperature is lowered from 30 °C to 0 °C, mainly due to an increase in solvent viscosity at 
lower temperatures. The viscosity of a 50% by volume mixture of methanol and water 
doubles as the temperature drops from 30 °C to 0 °C (1.43 to 2.84 centipoise (cP), 
respectively).2 Furthermore, lowering the temperature will alter the pH of the BGE, which 
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will affect the migration time of the analytes.31 For the electropherograms at lower 
temperatures, fronting was observed on the bradykinin and angiotensin II peaks, but this did 
not adversely affect the ability of the software to fit the peaks and the efficiency of each 
peptide still improved at the lower temperatures, illustrated by Figure 4.4. 
 
Figure 4.3. Microchip CE-ESI electropherograms of a 4-peptide mix at different temperatures (30 °C 
to 0 °C) and constant applied voltage, yielding a field strength of 1050 V/cm. Electropherograms 
offset for visualization. 
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The migration time relative standard deviation (RSD) for replicate injections at the 
same temperatures was 1.5% or lower for all peptides across the entire temperature range 
(data not shown). While this value is low, it corresponds to a decrease in migration time 
reproducibility based on previous work. Earlier publications with similar microchip CE-ESI 
devices yielded run-to-run reproducibility values of 0.3%.24,32 The increased migration time 
variability for replicate injections was due to drift in the temperature controlling unit during 
the course of the experiment. The temperature was observed to fluctuate by as much as ± 
0.5 °C during the timescale of a separation, resulting in variations of solvent viscosity and 
ultimately analyte migration time (data not shown). In the future, further optimization of the 
instrument could improve the temperature stability and yield improved run-to-run 
reproducibility on par with the performance of previous devices.  
Figure 4.4 plots the efficiency of each of the 4 peptides across the six different 
temperature points. For all peptides, there is a trend of increased theoretical plate count as the 
temperature is lowered. Error bars correspond to standard error (n = 3 to 6). Three out of the 
four peptides illustrate a high degree of linearity, with R2 values of 0.946 or higher. While 
the R2 value for angiotensin II is 0.789, there is still a trend of increased efficiency with 
lower temperatures. The small error bars on the plots indicate that the method used here is 
reproducible. According to the literature,12 the improvement in separation efficiency at lower 
temperatures and constant applied voltage can be estimated. By reducing the temperature 
from 30 °C to 0 °C, an improvement in the efficiency of 11% is expected. As illustrated by 
Figure 4, a much larger increase in separation efficiency was observed. Between the two 
temperatures, the efficiency of thymopentin, bradykinin, angiotensin II, and met-enkephalin 
improved 2.43 fold, 2.22 fold, 2.25 fold, and 1.65 fold, respectively.  
! 97!
Figure 4.4. Plot of efficiency versus temperature for the 4 peptides. Error bars represent standard 
error (n = 3 to 6). 
In order to assess the validity of the efficiency values in Figure 4 and investigate the 
disparity between the observed efficiency increase and that predicted by theory, the 
performance metric Δ, first described in a previous publication,24 was used. Briefly, Δ is a 
ratio that compares the apparent diffusion coefficient (Dapp) based on the spatial variance of a 
peak to the measured diffusion coefficient (Dm) for an analyte. A CE separation that was 
truly diffusion limited would have a Δ value of 1. Table 4.1 contains calculated Δ values for 
all 4 peptides at two different temperatures, 30 °C and 10 °C. The diffusion coefficients of 
the peptides were measured at the two temperatures using stopped flow experiments.  
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Table 4.1. Calculated Δ values of the 4 peptides at 2 different temperatures.  
  Thymopentin Bradykinin Angiotensin II Met-Enkephalin 
30 °C 3.90 4.07 4.89 2.01 
10 °C 2.10 2.34 3.44 1.46 
 
As illustrated by the table, the Δ values at 30 °C are between 3.90 and 4.89, with the 
exception of met-enkephalin (Δ = 2.01). As the temperature is lowered, the Δ values decrease 
for all 4 peptides to between 1.46 and 3.44. A change in the calculated Δ values could result 
from changes to both the measured and apparent diffusion coefficients for each peptide. 
Table 4.2 contains both values for each of the four peptides at 10 and 30 °C.  
Table 4.2. Dm and Dapp values (x 10-6 cm2/sec) for 4 peptides at 2 different temperatures.  
  Thymopentin Bradykinin Angiotensin II Met-Enkephalin 
  Dm Dapp Dm Dapp Dm Dapp Dm Dapp 
30 °C 2.89 11.27 2.94 11.97 2.09 10.24 2.57 5.16 
10 °C 1.46 3.06 1.77 4.15 1.27 4.38 1.48 2.17 
 
The diffusion coefficient for a spherical molecule is given by Equation 5, where k is 
Boltzmann’s constant, T is temperature, η is the solvent viscosity, and r is the hydrodynamic 
radius.33  
D = kT6πηr                    (5) 
Based on Equation 5, we would expect the measured diffusion coefficient to decrease 
roughly 40% between 10 °C and 30 °C. The Dm values at 30 °C are between 2.09 and 2.94 x 
10-6 cm2/sec, while the Dm values at 10 °C are between 1.27 and 1.48 x 10-6 cm2/sec, 
corresponding to a decrease of between 40% and 50%. The Dapp values for the peptides at 
30 °C fall between 1.197 x 10-5 and 5.16 x 10-6 cm2/sec, while the values at 10 °C are 
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between 2.17 and 4.38 x 10-6 cm2/sec. This corresponds to a decrease in the Dapp value 
between 2.3 and 3.7 fold, much larger than the corresponding decrease in the Dm values. 
Therefore, based on the values in Table 4.2, the observed decrease in the calculated Δ values 
was due to a proportionally larger decrease in the observed Dapp, as the decrease in the Dm 
values were similar to the expected result.  
Equation 2 describes the spatial variance of a band due to diffusion, which is 
proportional to both the diffusion coefficient (in this case Dm) and migration time.  As 
discussed earlier, the Dm values decreased between 40% and 50% as the temperature 
decreased from 30 °C to 10 °C. On the other hand, the migration times increase as the 
temperature decreases. At 30 °C, the migration times of the four peptides were as follows: 
thymopentin – 0.94 min, bradykinin – 1.09 min, angiotensin II – 1.18 min, and met-
enkephalin – 2.67 min. At 10 °C, the migration times of the four peptides were 1.64 min, 
1.91 min, 2.05 min, and 4.49 min, respectively. This corresponds to an increase in migration 
time of 79.7%, 75.2%, 73.7%, and 68.2% for the four peptides, respectively. Even though the 
Dm values decreased at the lower temperature, the corresponding increase in migration time 
was larger. This results in an increased spatial variance of the bands due to diffusion 
broadening. Therefore, at the lower temperature, it’s possible that diffusion broadening 
becomes more significant and the impact of other band broadening sources become less 
influential on the Δ value. This phenomenon can explain why the observed Δ values decrease 
at lower temperatures. Equation 6 illustrates that the total spatial variance (σ2TOT) of a band is 
the sum of variances based on different phenomena, such as diffusion (σ2DIFF), injection 
broadening (σ2INJ), detection broadening (σ2DET), wall interactions (σ2WALL), or Taylor 
dispersion due to Joule heating or a mismatch in EOF (σ2TAY).      
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   σ TOT
2 =σ DIFF
2 +σ INJ
2 +σ DET
2 +σWALL
2 +σ TAY
2                            (6) 
The Δ value essentially compares the total observed spatial variance of a band to the 
spatial variance of the band just due to diffusion. If the spatial variance of a band increased 
due to diffusion based on increased migration time, this could overshadow the other sources 
of spatial variance and result in a lower observed Δ value. Furthermore, as the temperature is 
lowered the viscosity increases. It’s feasible that an increase in viscosity would decrease the 
impact of any Taylor dispersion generated, which would also result in a lower Δ value. 
While the Δ values reported in this manuscript are higher than previous work 
published in our laboratory, they still indicate that the microchip was operating near the 
diffusion limit and represents an improvement over most of the CE-MS separations contained 
in the literature.24 Overall, the calculated Δ values (Table 4.1) for the peptides, as well as the 
measured and apparent diffusion coefficients (Table 4.2),  indicate the validity of the 
efficiency values in Figure 4.3 and explain why the observed increase in separation 
efficiency was higher than expected. At 30 °C, the microchip performance was further from 
ideal than at 0 °C. Lowering the temperature ameliorated these sources of band broadening, 
such as Taylor dispersion or wall interactions, and improved the efficiency and Δ values of 
the microchip. Additionally, one potential concern of lowering the temperature of a CE 
separation is the generation of an axial temperature gradient that would diminish the 
separation efficiency.12 However, the improved efficiency of each peptide at lower 
temperatures as demonstrated by Figure 4.3 as well as the Δ values in Table 4.1 indicate that 
an axial temperature gradient was not adversely affecting the performance of the chip. 
! 101!
At a constant electric field strength, lowering the temperature of a CE separation 
increases the separation run time as the viscosity increases, as illustrated in Figure 4.3. 
However, increasing the field strength should decrease the run time and further improve the 
separation efficiency based on the linear relationship between efficiency and the electric 
field.34 Figure 4.5 compares two electropherograms of the same 4-peptide mix at different 
temperatures with the same separation run time of approximately 4 min. The top 
electropherogram corresponds to a separation at 25 °C and 790 V/cm, while the bottom 
electropherogram corresponds to a separation at 0 °C and 1475 V/cm. At 25 °C, the 
migration times for the four peptides were 1.43, 1.64, 1.77, and 3.76 min, respectively, while 
at 0 °C the migration times were 1.50, 1.73, 1.85, and 3.70 min. At 25 °C, the average 
efficiency of thymopentin, bradykinin, angiotensin II, and met-enkephalin was calculated to 
be 102,000; 84,000; 87,000; and 65,000 plates, respectively. At 0 °C, the efficiency values 
were found to be 151,000; 174,000; 214,000, and 168,000 plates. For the electropherogram at 
0 °C, fronting was again observed on the bradykinin and angiotensin II peaks, but this did not 
adversely affect the efficiency of the peaks. Overall, these efficiency data indicate that the 
performance of the microchip agrees with the expected efficiency increase as the voltage is 
increased and the temperature is decreased. 
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Figure 4.5. Electropherograms of a 4-peptide mix at 25 °C and 790 V/cm electric field strength and 
at 0 °C and 1475 V/cm electric field strength. 
4.3.2 ESI Performance 
As illustrated in Figure 4.3, electropherograms of the same 4-peptide mix at different 
temperatures with constant applied voltage resulted in a decrease in peak height as the 
temperature was lowered. To further investigate the cause of this, a series of infusion 
experiments were used to probe the performance of ESI at different temperatures. Figure 4.6 
corresponds to infusion data of 500 nM fluorescein. The top plot shows the average BPI for 
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the fluorescein molecular ion (333 m/z) versus temperature. The hollow circles correspond to 
data with a field strength of 1050 V/cm. Similar to the trend in Figure 4.3, as the temperature 
is lowered, the BPI signal decreases. The bottom portion of the plot has the same Y-axis as 
the top portion (BPI), but the data are plotted against volumetric flowrate instead of 
temperature. As illustrated by the figure, at 30 °C, the flow rate is 120 nL/min with a BPI 
above 50. At 20 °C, the flowrate has decreased to 90 nL/min, but the BPI is still above 50. 
Below 20 °C, the flowrate decreases linearly from 80 nL/min down to 40 nL/min at 0 °C. 
This behavior corresponds well to the literature involving ESI at different flowrates. At high 
flowrates, ESI ionization is typically concentration sensitive; increasing the flowrate does not 
change the signal intensity. However, at lower flowrates, typically below 100 nL/min, ESI 
transitions to mass-sensitive, where changing the flowrate can change the sensitivity.35,36 The 
plot illustrates that as the temperature is lowered at a constant applied voltage, the flowrate 
decreases based on the increase in viscosity, causing the signal intensity to decrease. The 
black square corresponds to infusion at an increased field strength (1475 V/cm). At 0 °C, 
increasing the field strength increases the signal intensity showing the mass-sensitivity for 
sub-100 nL/min flowrates.  
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 !
Figure 4.6. Infusion data of 500 nM fluorescein. Error bars represent standard error (n=6). The top 
plot and the bottom plot share the same Y-axis, but the X-axis is plotted as either temperature (top) or 
volumetric flowrate (bottom). 
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Figure 4.7 illustrates the calculated peak area for each peptide in Figure 4.3 measured 
against temperature. As illustrated by the figure, a trend of decreasing peak area was 
observed as the temperature was lowered at a constant field strength. However, during this 
experiment, no attempt was made to optimize the operation of the electrospray in terms of 
applied voltage, flowrate, and position relative to the MS inlet, all of which can alter the 
observed ESI sensitivity.37 In the future, optimal ESI conditions at each temperature can be 
investigated. Furthermore, these observations help explain the increase in signal intensity in 
the electropherogram at 0 °C at higher field strength in Figure 4.5.   
 
Figure 4.7. Calculated peak area for 4-peptide mix at various temperatures. The field strength was 
1055 V/cm. 
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4.3.3 Hydrogen/Deuterium Back Exchange 
In order to demonstrate the potential utility of low temperature CE for HX MS 
experiments, a hydrogen/deuterium back exchange experiment was performed. The BGE 
solvent was switched from methanol to the lower viscosity solvent acetonitrile to decrease 
the separation run time and therefore minimize the window for back exchange. An 
undeuterated sample of a 3-peptide mixture was separated at 25 °C and 875 V/cm and 
compared to a fully deuterated mixture separated under various conditions. For the 
deuterated samples, the remainder of the chip was filled with non-deuterated BGE; therefore, 
back-exchange began to occur upon injection of the sample into the separation channel. The 
time that back-exchange could occur for each peptide was equal to the migration time. The 
deuterated peptide samples were separated at 25 °C, 875 V/cm; 0 °C, 875 V/cm, and 0 °C, 
1475 V/cm. By altering both the temperature and the field strength, the effects of temperature 
and migration time on deuterium retention are investigated. Based on the acquired mass 
spectra the relative deuterium uptake (R.D.U.) can be calculated (Equations 3 and 4) 
representing the average number of deuterium molecules retained on the analyte at the time 
of detection. Minimizing back-exchange correlates to higher R.D.U. values.  
Figure 4.8 illustrates the mass spectra of the 2+ charge state of angiotensin II under 
the four conditions listed. The top spectrum, labeled A, corresponds to the undeuterated 
peptide. The spectrum labeled B corresponds to deuterated angiotensin II separated at 25 °C 
and 875 V/cm; C corresponds to 0 °C, 875 V/cm; and D correspond to 0 °C, 1475 V/cm. The 
migration time for angiotensin II for spectra A, B, and D was 55 s, while the migration time 
was 95 s for spectrum C. For a 50% volume/volume acetonitrile and water mixture, lowering 
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the temperature from 25 °C to 0 °C will increase the viscosity by around 50% (0.82 to 1.27 
cP).2  
 Figure 4.8. Mass spectra of 2+ charge state of Angiotensin 
II. A – undeuterated sample at 25 °C, 875 V/cm. B – 
deuterated sample at 25 °C, 875 V/cm. C – deuterated 
sample at 0 °C, 875 V/cm. D – deuterated sample at 0 °C, 
1475 V/cm. R.D.U. corresponds to relative deuterium 
uptake. 
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Furthermore, lowering the temperature will alter the pH of the BGE and therefore 
affect the analyte migration times.31 From spectrum B, the calculated R.D.U. value was 3.61, 
indicating an average of over 3 deuterium molecules retained on angiotensin II. Lowering the 
temperature while keeping the field strength constant increased the migration time from 55 to 
95 s; the calculated R.D.U. value under these conditions increased to 5.58, as shown in 
Figure 4.8C, indicating improved deuterium retention. Finally, lowering the temperature to 
0 °C and increasing the field strength to decrease the migration time resulted in the highest 
calculated R.D.U. value of 6.09 (Figure 4.8D). The other peptides in the mix followed the 
same trend; Table 4.3 contains the migration time and calculated R.D.U. values for 
thymopentin and bradykinin.  
Table 4.3. Calculated relative deuterium uptake values for peptides at various conditions. 
Thymopentin 
   Temperature 
(°C) 
Field Strength 
(V/cm) Migration Time (s)  R.D.U. 
25 875 45 1.92 
0 875 80 3.5 
0 1475 45 3.7 
    Bradykinin 
   Temperature 
(°C) 
Field Strength 
(V/cm) Migration Time (s)  R.D.U. 
25 875 49 3.63 
0 875 88 5.89 
0 1475 49 6.49 
 
As demonstrated by Figure 4.8 and Table 4.3, lowering the temperature increased 
deuterium retention for all three peptides observed, as expected. This result demonstrates that 
back exchange had been decreased and illustrates the utility of low temperature CE for HX 
MS experiments. A previous publication in our laboratory detailed the use of CE-ESI for HX 
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MS experiments, but lacked temperature control to reduce back exchange. Future 
experiments will investigate the use of low temperature CE for HX MS labeling experiments 
to take advantage of the fast and efficient nature of CE in comparison to LC while 
maintaining or improving deuterium retention rates. 
4.4 Conclusions 
In this report, we demonstrated a method for performing microchip CE-ESI at low 
temperatures to study the fundamental performance of CE as a function of temperature and 
for utilization in HX MS experiments. The temperature of the microchip was controlled using 
an in-house-built Peltier cooling device. A mixture of four peptides was separated at 
temperatures between 30 °C to 0 °C at a constant applied voltage. As the temperature was 
lowered, the migration time of the analytes increased as expected based on the higher solvent 
viscosity. The efficiency of each peptide from the constant applied voltage 
electropherograms was plotted against temperature; for all peptides, a clear trend of 
increasing efficiency as the temperature was lowered was demonstrated. For three out of four 
peptides, a high degree of linearity was observed (R2 values > 0.94), in good agreement with 
CE theory. A separation of a peptide mixture at 25 °C was compared to a separation of the 
same sample at 0 °C. The electric field was modified to keep the separation run time constant. 
Comparing the efficiency of the analytes between the two electropherograms resulted in 
improved plate numbers for each peptide, as expected based on the higher electric field. 
These results indicate that increasing the electric field, yielding further improvements to 
separation efficiency, can offset the higher migration times seen at lower temperatures. An 
infusion experiment was performed to demonstrate that the observed decrease in peak height 
was due to decreasing flowrate, and that increasing the electric field can offset the lower 
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signal intensity. Finally, a hydrogen/deuterium back-exchange experiment was performed at 
25 °C and 0 °C. The results demonstrated that lowering the temperature increased the relative 
deuterium uptake of three peptides, indicating the utility of low temperature CE-ESI for HX 
MS analysis.    
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CHAPTER 5: INTEGRATING SOLID PHASE EXTRACTION AND TRANSIENT 
ISOTACHOPHORESIS WITH MICROCHIP CAPILLARY ELECTROPHORESIS – 
ELECTROSPRAY IONIZATION 
5.1 Introduction 
Since its introduction in the early 1980’s,1 capillary electrophoresis (CE) has become 
a popular separations technique with numerous applications such as illicit drug detection,2 
fatty acid characterizaion,3 and the analysis of a wide variety of biomedical analytes.4 CE 
possesses many advantages including high separation efficiencies, fast run times, small 
sample requirements, and a wide analysis scope. However, CE is not without its 
disadvantages. CE often suffers from poor sensitivity and exhibits a low tolerance for matrix 
components, regularly necessitating sample processing prior to analysis.5 Combining 
separations with mass spectrometry (MS) detection has become increasingly critical in many 
bioanalytical applications, based on the high sensitivity, selectivity, and chemical 
information provided by the MS detector.6,7 However, coupling CE with electrospray 
ionization (ESI) further reduces salt tolerances and can lower sensitivity via sheath flow, 
compounding the necessity for sample treatment prior to analysis.8  
Based upon the substantial need, coupling CE to sample processing techniques has 
been a considerable point of emphasis in recent years. Most of the efforts to integrate sample 
processing with CE can be classified as either electrophoretic or chromatographic based. 
Electrophoretic based techniques, including sample stacking, sweeping, pH induced stacking, 
and transient isotachophoresis (tITP), are typically simple to implement and require little 
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instrumentation development.9-12 Unfortunately, these techniques cannot typically load a 
sample volume larger than the volume of the capillary which limits the achievable pre-
concentration and sensitivity improvement.13 Furthermore, electrophoretic methods often 
concentrate matrix components equally to the analytes of interest, which can reduce 
separation performance.14 Finally, these methods can be limited to a narrow scope of analyte 
and buffer conditions, and may not be as widely applicable as other sample processing 
techniques.10  
On the other hand, chromatographic-based techniques, such as solid phase extraction 
(SPE), are typically more versatile than electrophoretic-based methods and can offer higher 
pre-concentration values based on the ability to load multiple capillary volumes onto the 
chromatographic sorbent.15 However, these methods present their own shortcomings. In-line 
coupling is defined as the inclusion of the SPE sorbent at the head of the CE capillary. The 
presence of the SPE sorbent in the separation capillary can lead to clogging and disruption of 
the electroosmotic flow (EOF), reducing separation performance. Furthermore, in this 
scenario, matrix components enter the separation capillary, which can lead to wall 
interactions and further diminish the separation performance.13-15 On-line coupling, where the 
SPE sorbent is separate from the CE capillary but connected via a flow stream with tubing 
and valves, is the most common method for combining SPE with CE. The decoupling of the 
SPE sorbent from the CE capillary prevents clogging and EOF disruption. Additionally, the 
inclusion of valves between the SPE sorbent and the CE capillary can direct the matrix 
components to waste and prevent them from entering the CE capillary. Unfortunately, on-line 
coupling of SPE and CE often requires complex instrumentation. Furthermore, the transfer of 
the sample band from the SPE sorbent to the CE capillary typically introduces band 
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broadening, limiting the resulting separation performance.13-15 Additionally, dead volume 
present in the on-line system can dilute the concentrated analyte band, reducing the amount 
of pre-concentration that can be achieved. Overall, it has been demonstrated that coupling 
sample processing with CE without sacrificing the separation performance is a very 
challenging task; and despite recent research efforts, CE still lags considerably behind liquid 
chromatography (LC) with regards to integrated sample processing that is robust, widely 
applicable, and does not compromise separation performance.  
Based on the limitations of coupling sample processing with CE, a microfluidic 
platform presents a very promising candidate for an integrated SPE-CE system. Microfluidic 
technology is well suited towards integrating multiple functional components and can 
precisely manipulate small volumes with zero dead volume.16,17 Furthermore, lab-on-a-chip 
technologies are amenable to automation, resulting in improved reproducibility and 
throughput.18-20 On-line coupling of SPE-CE presents a promising approach for maximizing 
both sample processing and separation performance, and utilizing microfluidic technology 
can overcome the obstacles observed with the previous bench top designs reported. The 
coupling of SPE and CE on a microfluidic device has been described previously in the 
literature;21-30 however, the sample processing resulted in decreased separation performance.  
The most likely cause of the poor separation efficiencies is injection broadening due to the 
introduction of band broadening during the SPE elution and transfer step. Furthermore, only 
a handful of reports utilized MS detection,31-34 and these focused on the analysis of only a 
few components and not the separation of complex mixtures.     
In this study, an improved design for integrating on-line SPE with microchip CE-ESI 
is presented. The pre-concentration, separation performance, and reproducibility of the 
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integrated SPE-CE-ESI method was investigated using a four peptide mix. In order to 
eliminate band broadening imparted on the sample during the transfer between the SPE bed 
and CE capillary, transient isotachophoresis (tITP) was utilized to refocus the analyte band 
prior to separation. tITP is a non-linear electrophoretic focusing technique where the sample 
is sandwiched between a leading fast moving electrolyte (LE) and a trailing slower moving 
electrolyte (TE). Sample analytes will focus into discreet zones based upon their 
electrophoretic mobilities.35 By utilizing this technique, band broadening imparted onto the 
sample during the SPE elution and transfer step can be reduced, resulting in a narrow 
injection plug necessary for a high performance separation. The ability of this device to 
analyze complex mixtures was investigated by separating a Phosphorylase B tryptic digest as 
well as an E. Coli tryptic digest. Sample pre-concentration factors of more than three orders 
of magnitude were observed without any reduction in separation performance. Overall, this 
device represents a superior platform for integrating sample processing with CE-ESI-MS. 
  
! 117!
5.2 Experimental 
5.2.1 Reagents and Materials 
LC-MS grade acetonitrile, methanol, acetone, and formic acid (99.99%) were 
acquired from Fisher Chemical (Fairlawn, NJ) as well as HPLC grade ammonium acetate and 
trifluoroacetic acid (TFA) (99.975%). Water was purified with a Nanopure Diamond water 
purifier (Barnstead International, Dubuque, IA). (3-Amino)di-isopropylethoxysilane 
(APDIPES) was acquired from Gelest (Morrisville, PA).  Sodium phosphate dibasic, 
trichloro(1H,1H,2H,2H-perfluorooctyl)silane was acquired from Sigma-Aldrich (St. Louis, 
MO). N-hydroxylsuccinimide functionalized polyethylene glycol (NHS-PEG) reagent with 
450 polymer units (MW = 20 kDa) was purchased from Nanocs, Inc. (Boston, MA). Met-
enkephalin, bradykinin, angiotensin II, thymopentin, and human glu-fibrionpeptide were 
purchased from American Peptide Company (Sunnyvale, CA). MassPREP Phosphorylase B 
and E. Coli digest were procured from Waters Corporation (Milford, MA).   
5.2.2 Microchip Design, Fabrication, and Surface Coating 
A schematic for the SPE-CE-ESI microchip can be found in Figure 5.1. The 
microchip was fabricated out of 550 µm thick D263 glass using standard photolithography, 
wet chemical etching, and thermal bonding techniques.36,37 All channels were 10 µm deep 
and 70 µm wide (full-width). The microchip was then coated with APDIPES and modified 
with an NHS-PEG reagent as described previously.38,39 
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Figure 5.1. Schematic and experimental set up of the SPE-CE-ESI microchip. The separation channel 
(S) is 23 cm long, and all channels are 10 µm deep. Applied voltage, pressure, and vacuum are 
controlled by a computer with a Labview program. The dimensions of the SPE bed are not to scale, 
but enlarged to show location.  
5.2.3 Microchip CE-ESI Operation 
To perform CE-ESI separations, sample dissolved in BGE was placed in the reservoir 
labeled 1 and a gated injection40 was performed. Microchips were operated by the application 
of voltages to the solvent reservoirs, as previously described;36-38 no pressure was used for 
these CE-ESI separations. For the CE-ESI separation, voltages of +22, + 22, + 20, and + 1.7 
kV were applied to the reservoirs labeled 1, 2, 3, and 4, respectively. To inject sample, the 
voltages were changed to +22, +21, + 21, and +1.7 kV, respectively. The injection time was 
0.4 seconds. The applied voltages resulted in a field strength of 760 V/cm. The background 
! 119!
electrolyte (BGE) for the separations was 50:50 acetonitrile:2% formic acid in water (v/v), 
pH 2.2.   
5.2.4 Microchip SPE-CE-ESI Operation  
To perform integrated sample processing, SPE-CE-ESI microchips were packed with 
5 µm diameter porous Oasis HLB particles provided by Waters Corporation (Milford, MA). 
The SPE bed was packed against a microfabricated weir by placing a slurry of 0.1 mg/mL 
Oasis HLB particles in acetone in reservoir 2 and applying vacuum to reservoir 3 (Figure 5.1).  
The length of the packed bed was 600 µm long, while the channel depth and width were 10 
µm and 70 µm, respectively. The volume of the packed bed was estimated to be 425 pL. The 
time required to pack the SPE bed on the microchip was 10 minutes.  
To perform SPE-CE-ESI, the bed was first conditioned with low organic solvent. A 
95:5 0.1% formic acid in water:methanol (v/v) solution was placed in reservoir 2. Head 
pressure (+ 0.69 bar) from a tank of compressed nitrogen was applied to reservoir 2 while 
simultaneously applying vacuum to reservoir 3 for 30 seconds. To load sample onto the SPE 
bed, the desired sample was placed in reservoir 2. Unless otherwise noted, the sample was 
dissolved in 2:98 methanol:0.5% TFA in water (v/v). The same pressure and vacuum were 
applied to the sample and waste reservoir, respectively, for 5 minutes. Finally, elution solvent 
replaced the sample in reservoir 2. For SPE-CE-ESI, the elution solvent was 80:20 
acetonitrile:2% formic acid in water (v/v).  
For SPE-tITP-CE-ESI, the elution solvent was the same with the addition of 100 mM 
ammonium acetate. To perform an elution, the procedure was the same for both the SPE-CE-
ESI and SPE-tITP-CE-ESI methods. First, + 0.69 bar was applied to reservoir 2 for one 
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second. Next, + 0.69 bar was applied to both reservoirs 1 and 2 for four seconds. This 
resulted in the eluted analyte band entering the separation channel. Next,  +0.69 bar was 
applied to reservoir one, which cleared the injection cross of excess sample prior to the 
application of voltage and creation of the injection plug. Finally, voltage was applied to 
reservoirs 1 (+22 kV) and 4 (+1.5 kV). The applied voltages resulted in a field strength of 
760 V/cm.  The application of the pressure and vacuum to the chip was controlled using a 3-
way electronic valve (Clippard, Inc., Cincinnati, OH), which was operated by an SCB-68 
breakout box connected to a PC via a PCI 6713 DAQ card (National Instruments, Austin, 
TX) and controlled by a Labview program. The BGE for all SPE-CE-ESI and SPE-tITP-CE-
ESI separations was 50:50 acetonitrile:2% formic acid in water, pH 2.2. 
5.2.5 Separation of a Four Peptide Mix 
A four peptide mix (thymopentin, bradykinin, angiotensin II and met-enkephalin) was 
used to compare figures of merit for the three different methods investigated. A Waters 
Synapt G2 quadrupole time-of-flight (qTOF) mass spectrometer was used (Waters 
Corporation, Milford MA). The instrument was set to MS Sensitivity mode with a mass 
range of 300 – 600 m/z and a summed scan time of 0.09 seconds. 
5.2.6 Electrokinetic and Hydrodynamic Injection Comparison 
 To compare differences in observed peak area between an electrokinetic gated 
injection and a hydrodynamic injection, microchip CE-ESI was used to separate a 5 µM four 
peptide mix (thymopentin, bradykinin, angiotensin II and met-enkephalin). A 23 cm CE-ESI 
microchip was utilized. The design is very similar to the microchip described in Figure 5.1, 
however, no weir was present in the channel connected to reservoir 2, and no SPE bed was 
! 121!
present. The depth and the width of the channels was the same as the SPE-CE-ESI microchip, 
as well as the surface coating. The BGE and MS settings were the same as those described 
earlier. For the electrokinetic injection, the applied voltages were 22, 22, 20, and 2 kV, 
respectively. The duration of the gated injection was 0.4 s. For the hydrodynamic injection, 
0.165 bar of head pressure was applied to reservoirs 1 and 2 simultaneously for 3 seconds. 
This resulted in sample entering the separation channel. Next, 0.165 bar of pressure was 
applied to reservoir 1 for one second, which cleared the injection cross of excess sample 
creating the injection plug in the separation channel. Finally, applied voltages of 22 kV and 2 
kV were applied to reservoirs 1 and 4, respectively. The analyte volumes for the injections 
were calculated by multiplying the volumetric flowrate (linear velocity x cross sectional area) 
and the injection time. 
5.2.7 Sample Carry Over 
Sample carry over was investigated for both the CE-ESI microchip and the SPE-CE-
ESI microchip. For both techniques, a sample of the four peptide mix was separated at either 
5 µM or 50 nM, respectively. Directly following the separation, the reservoir that contained 
the sample was rinsed by removing the sample and filling the reservoir with BGE. The 
solution was mixed by aspirating with a pipette. This process was repeated three times and 
then the reservoir was filled with a blank. For the CE-ESI microchip, the blank consisted of 
BGE. For the SPE-CE-ESI microchip, the blank consisted of 2% methanol, 0.5% 
trifluoracetic acid, and 97.5% water. For both techniques, the same sample loading and 
injection procedures that were used for the peptide mix was applied to the blank. The mass 
spectrometer settings were the same as those described for the separation of the 4-peptide 
mix. 
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5.2.8 Protein Digest Separations 
A tryptic digest of Phosphorylase B was separated using both CE-ESI (5 µM) and 
SPE-tITP-CE-ESI (50 nM). Additionally, 0.5 mg/mL E. Coli digest was analyzed using SPE-
tITP-CE-ESI. A Waters Synapt G2 qTOF was used to perform MSE. The instrument was set 
to MS/MS Sensitivity mode with a mass range of 50 – 1200 m/z and a summed scan time of 
0.05 seconds. Human Glu-fibrinopeptide precursor was used as a lockmass compound, as 
described earlier.41 
5.2.9 Data Processing 
To determine peak width and area, extracted ion electropherograms were exported 
into the program Igor Pro (Wavemetrics, Lake Oswego, Oregon) and the analysis package 
multi-peak fit 2 was used. To determine the peak capacity, base peak index (BPI) 
electropherograms were exported to the program PeakFinder (Pacific Northwest National 
Laboratory), which measured the separation window and median 4σ peak width.  
The Phosphorylase B digest electropherograms were analyzed using the software 
Biopharmalynx (Waters Corporation) to determine the number of peptides observed. The 
method was based on a trypsin enzyme digest with up to two missed cleavages permitted. 
The MS and MSE mass tolerances were both set to 30.0 ppm. The MS ion intensity threshold 
was set to 25 counts, while the MSE ion intensity threshold was set to 10 counts. Only 
peptides with an intensity value greater than or equal to 1% of the most intense peptide were 
counted.
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5.3 Results and Discussion 
5.3.1 Separation and Pre-concentration Performance 
To investigate the concentration and separation performance of the integrated sample 
processing microchip three different approaches were compared; conventional CE-ESI, SPE-
CE-ESI, and SPE-tITP-CE-ESI. All microchips were coupled directly with MS for detection. 
To ensure the separation conditions were identical for all methods, the CE separations were 
performed using the SPE-CE-ESI device without any stationary phase. Microchip CE-ESI 
separations were performed using a gated electrokinetic injection, while the SPE-CE-ESI and 
SPE-tITP-CE-ESI methods used a hydrodynamic injection. As long as the injection volume 
is sufficiently low to prevent injection broadening, the injection method will not have any 
influence on the separation performance. The affect of the injection method on the sensitivity 
of the methods is explored later. Figure 5.2 compares the electropherograms for the three 
techniques while Table 1 compares the figures of merit. Theoretical plates are not an accurate 
measure of separation efficiency when tITP is coupled with CE, as the field strength is not 
linear across the channel for the duration of the separation. Since peak capacity does not 
require a linear electric field, it was therefore employed as a more accurate performance 
metric. 
Figure 5.2 shows representative electropherograms from the three techniques. The 
peaks are labeled 1 through 4, and correspond to thymopentin, bradykinin, angiotensin II, 
and met-enkephalin, respectively. Peaks A (1087.5 Da) and B (1073.5 Da) correspond to 
unidentified trace peptides that were observed in the SPE-CE-ESI and SPE-tITP-CE-ESI 
electropherograms. The top electropherogram corresponds to the CE-ESI analysis of a 5 µM 
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peptide mix. The observed migration times for the four peptides were 1.64, 1.84, 1.98, and 
4.19 min, respectively with a total separation time of just over four minutes long. The 
efficiency values for the CE-ESI approach were between 90,000 and 133,000 theoretical 
plates. The average peak capacity observed was 105.5, with a median 4σ peak width of 1.45 
seconds and a separation window of 152.95 s (n=3).  By using these figures of merit as a 
baseline, we can compare the separation performance of the SPE-CE-ESI and SPE-tITP-CE-
ESI methods. 
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Figure 5.2. Electropherograms of 4-peptide mix. Top – CE-ESI of 5 µM sample. Middle – SPE-
CE-ESI of 50 nM sample. Bottom – SPE-tITP-CE-ESI of 50 nM sample. A and B correspond to 
unidentified trace components. 
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          The middle electropherogram corresponds to the SPE-CE-ESI analysis of 50 nM 
peptide mix, 100 times more dilute than the sample used for the CE-ESI separation. The 
migration time of the four peptides was 1.72, 1.92, 2.07 and 4.27 min respectively, very 
similar to the migration times for the CE-ESI electropherogram. Peak 5, at 4.50 min 
corresponds to oxidized met-enkephalin, which was not visible in the CE-ESI 
electropherogram, indicating the concentration enhancement of the SPE-CE-ESI approach. 
The theoretical plate counts of the four peptides using the SPE-CE-ESI method were 
between 39,000 and 92,000 theoretical plates and the observed peak capacity for the SPE-
CE-ESI method was decreased to 66.5, with a median 4σ peak width of 2.30 s and a 
separation window of 152.95 s (n=3) (Table 5.1). These values did not take the oxidized 
met-enkephalin peak (peak 5) into account. 
Table 5.1. Calculated peak capacity and efficiency values for 4-peptide mix 
  Peak Capacity Thymopentin Bradykinin Angiotensin II Met-Enkephalin 
CE-MS 105.5 107,526 90,583 109,349 132,782 
SPE-CE-MS 66.5 39,061 41,945 45,731 91,979 
SPE-tITP-CE-MS 174.5 407,571* 311,383* 300,563* 153,868* 
*Apparent efficiency values calculated based on peak width and migration time 
To investigate the amount of pre-concentration observed an enrichment factor was 
calculated for each of the four peptides. To characterize the effect of the different injection 
methods (hydrodynamic versus electrokinetic), microchip CE-ESI of the same four peptides 
was performed using both injection methods. The volume of analyte injected into the 
separation channel for an electrokinetic gated injection depends on the electrophoretic 
mobility of the analyte.42 For a hydrodynamic injection, the volume should be constant for all 
analytes. When comparing the pre-concentration performance of the SPE-CE-ESI and SPE-
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tITP-CE-ESI methods, it is important to distinguish if any increase in observed sensitivity is 
due to pre-concentration of analyte on the bed or due to the removal of electrokinetic bias. 
Figure 5.3 illustrates the electropherograms for the electrokinetic (top) and hydrodynamic 
(bottom) injections for the four peptide mix. The peptides are labeled 1 through 4, 
corresponding to thymopentin, bradykinin, angiotensin II, and met-enkephalin. For the 
electrokinetic injection, the injection volumes of peaks 1 through 4 were calculated to be 585, 
522, 482, and 215 pL, respectively. For the hydrodynamic injection separation, the injection 
volume was matched to the largest volume from the electrokinetic injection, and was 
calculated to be 600 pL. As illustrated by the figure as well as the injection volumes, the 
electrokinetic bias increases as the analyte migration time increases, corresponding to 
peptides with lower electrophoretic mobilities. The observed bias is especially prevalent for 
met-enkephalin (peak 4), while the average (n=3) peak heights for peaks 1 through 3 are 
within 20% of each other for each pair. 
 
Figure 5.3. Electropherograms of a four peptide mix comparing electrokinetic injection (top) versus 
hydrodynamic injection (bottom). 
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From the electropherograms in Figure 5.3, the average (n=3 replicate injections) peak 
areas were calculated and compared between the two methods. Figure 5.4 plots the calculated 
peak areas versus migration time for each of the four peptides. As illustrated by the figure, no 
significant difference in peak area was observed for the first three peptides (peaks 1 through 
3). However, a significant difference was observed for the met-enkephalin peak, the peptide 
with the lowest electrophoretic mobility, and therefore the highest electrokinetic bias. To 
account for this difference in sensitivity, a correction factor can be calculated by using a ratio 
of the electrokinetic injection peak area to the hydrodynamic injection. For met-enkephalin, 
this value was calculated to be 0.31, which is similar to the calculated difference in injection 
volume (215 v. 600 pL).    
 
Figure 5.4. Peak area comparison of microchip CE-ESI of four peptides for electrokinetic and 
hydrodynamic injections. 
For the SPE-CE-ESI method, the enrichment values were 78, 712, 713, and 799 for 
peaks 1-4, respectively (Figure 5.2). The enrichment factor was calculated by multiplying the 
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difference in initial analyte concentration (100) by a ratio of the SPE-CE-ESI peak area 
compared to the CE-ESI peak area. For the met-enkephalin peak, the correction factor (0.31) 
was also used to account for the difference in peak area due to the differences in injection 
method.  
The enrichment factor will vary due to differences in retention on the SPE bed as well. 
Thymopentin (Peak 1), a small (679.76 Da), hydrophilic peptide was not well retained on the 
hydrophobic stationary phase and thus had a much lower enrichment factor compared to the 
other peptides. Without the addition of TFA (0.5%) to the sample, thymopentin was not 
retained at all on the stationary phase (data not shown). Therefore, the lower observed 
enrichment factor of thymopentin compared to the other peptides was expected. TFA is an 
ion-pairing agent commonly used in chromatography, however, it is typically incompatible 
with ESI due to ion-suppression effects.43,44 The SPE-CE-ESI approach does not suffer this 
limitation, as TFA can be employed to retain the sample but is then removed prior to elution. 
The ability to utilize TFA to improve retention of analytes on the SPE bed without 
compromising ESI performance represents a significant advantage of the SPE-CE-ESI 
microchip compared to LC-MS instruments where the TFA content is introduced directly 
into the mobile phase. The enrichment factors for bradykinin and angiotensin II were 
approximately 700, while the calculated value for met-enkephalin was 799. Overall, a 
significant amount of pre-concentration was observed using the SPE-CE method for the 
peptide mix. However, the resulting separation performance was reduced to roughly half that 
of the CE-ESI method, highlighting the challenge of coupling sample processing with CE-
ESI while maintaining separation performance.  
! 130!
In order to regain the separation performance lost using the SPE-CE-ESI method 
while maintaining the observed pre-concentration, tITP was used prior to the CE-ESI 
separation.  As tITP is a focusing technique, it produced a narrow injection band, eliminating 
any band broadening introduced by the transfer of the analyte band from the SPE bed to the 
CE channel. The bottom electropherogram in Figure 5.2 corresponds to the analysis of 50 nM 
peptide mix using the SPE-tITP-CE-ESI method. The procedure for this method is identical 
to the SPE-CE-ESI technique, except that 100 mM ammonium acetate was added to the 
elution solvent. The ammonium acts as the leading electrolyte and the formic acid in the 
BGE acts as the trailing electrolyte. Directly after the application of voltage to the microchip, 
the sample undergoes tITP focusing. Following the focusing step, the sample transitions to a 
CE separation. The migration times for the peptides are 1.68, 1.86, 1.98, and 3.98 min, 
respectively. Compared to both the CE-ESI and SPE-CE-ESI electropherograms, the 
separation window was compressed in the SPE-tITP-CE-ESI electropherogram due to the 
tITP focusing step. The average peak capacity observed was 174.5, with a median 4σ peak 
width of 0.81 s and a separation window of 141.33 s (n=3). This is nearly double compared 
to the CE-ESI separation, and nearly triple that for the SPE-CE-ESI method. The enrichment 
values for the four peptides were calculated to be 72, 614, 660, and 783, respectively. As 
evident by both the calculated peak capacity and enrichment values, the separation 
performance for the SPE-tITP-CE method is greatly improved compared to the CE and SPE-
CE methods while providing a significant amount of sample pre-concentration.  
Finally, to demonstrate the robustness of the developed methods the migration time 
reproducibility, peak area reproducibility, sample carryover, and limits of detection were 
investigated. For three replicate injections of the peptide mix, the average migration time 
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RSD values were 0.23% for CE-ESI, 0.49% for SPE-CE-ESI, and 0.94% for SPE-tITP-CE-
ESI. The average peak area RSD values were 7.08%, 5.26%, and 8.66%, respectively. These 
values indicate that both the SPE-CE-ESI and SPE-tITP-CE-ESI methods are reproducible, 
with migration time and peak area RSDs below 1 and 10%, respectively. To determine the 
limit of detection (LOD), the signal to noise (S/N) ratio of each peptide was calculated and 
then extrapolated to a S/N of 3. For the CE-MS method, the LOD of peaks 1 through 4 were 
calculated to be 800, 700, 400, and 700 nM, respectively. For the SPE-tITP-CE-MS method, 
the values were 3.0, 2.2, 2.6, and 1.7 nM, respectively, indicating more than two orders of 
magnitude lower LOD for the method with integrated sample processing. Sample carryover 
was compared for the SPE-CE and compared to the CE method. Following the separation of 
a four peptide mix (CE – 5 µM, SPE-CE – 50 nM), a blank was analyzed. Sample carryover 
was characterized by observing detection of any peptides in the blank electropherogram. For 
the CE electropherograms, no sample carryover was detected. For the SPE-CE 
electropherogram, carryover was only observed for bradykinin, the peptide with the most 
intense signal, yielding a peak area value of only 0.04% of the initial peak. This sample 
carryover is considered negligible and further optimization of wash steps between samples 
will likely eliminate it completely. The sample carryover performance of the SPE-CE-ESI 
method can be extrapolated to the SPE-tITP-CE-ESI method. The presence of salt in the 
elution solvent is the only difference between the two methods with all other steps identical, 
including the sample loading step and a wash step of the SPE bed following elution. 
Therefore, any residual material left on the SPE bed would be identical between the two 
methods. The high enrichment factors, low RSD values, low sample carryover and 
! 132!
improvement in separation performance demonstrate the viability of this method for analyte 
pre concentration for CE-ESI.  
5.3.2 Dynamic Range and Overloading 
When employing a stationary phase to pre-concentrate samples it is essential to 
ensure that the bed does not become saturated in the desired concentration range. The 
integrated SPE-tITP-CE-MS method possesses three dimensions that are subject to sample 
overloading; the CE separation, the MS detector, and the adsorbent bed. As the sample is 
being continually loaded onto the adsorbent bed both volume and mass overloading must be 
considered. Volume overload occurs when a large volume (orders of magnitude larger than 
the volume of the stationary phase bed) of sample is injected onto the bed. Even under 
solvent conditions designed for sample adsorption (low organic), the large volume can cause 
weakly retained analytes to partition into the mobile phase and be eluted from the bed. Mass 
overload occurs when the amount of analyte injected exceeds the capacity of the stationary 
phase, saturating the bed with sample. It can be difficult to assign the effects of overloading 
to the saturation of the stationary phase alone and experiments must be carefully designed to 
ensure that it is characterized appropriately.  
In order to determine the applicable dynamic range for the SPE-tITP-CE method the 
four peptide mix was investigated. The concentration range explored was 1, 10, 100, 1000 
and 10000 nM. Figure 5.5 illustrates the BPI electropherograms for the peptide mix between 
10 nM and 10 µM. The peptides were not visible in the BPI electropherogram of the 1 nM 
sample, but were observed in the extracted ion electropherogram. As demonstrated by Figure 
5.5, the peak height and area for the four peptides increased as the concentration increased. 
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The peak shape became distorted at high concentrations, and it appears that the detector 
becomes saturated. Furthermore, trace impurities were also present in the four peptide mix, 
and were observed at higher concentrations. Two of these impurities were labeled peptide A 
and B. The concentration of peptide A and B in the mixture were unknown, but it’s estimated 
that they were at least an order of magnitude less concentrated than the four sample peptides.  
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Figure 5.5. SPE-tITP-CE-ESI electropherograms of increasing concentrations of a 4-peptide mix.  
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Figure 5.6. Plots illustrating peak area, width, and height for SPE-tITP-CE-ESI analysis of 
bradykinin, thymopentin, and an unidentified trace component labeled peptide A. The concentration 
of the peptide mix loaded ranged from 1 nM to 10 µM. Sample concentration reflects the 
concentration of the 4 peptides in the mixture (thymopentin, bradykinin, angiotensin II, and met-
enkephalin) and does not represent the concentration of the trace components A and B.    
Figure 5.6 illustrates the peak area, width, and height of bradykinin, thymopentin, and 
peptide A over the range of concentrations tested. To determine overloading in the CE 
domain the peak width of bradykinin and peptide A were compared. The peak width of 
bradykinin remains unchanged from 1 nM to 100 nM. Above 100 nM, the peak width sharply 
increases. On the other hand, the peak width of the peptide A remains similar over the range 
of concentrations. This suggests that the CE separation has been saturated for the well-
retained, highly abundant analyte. Figure 5.5 visually supports this conclusion. Monitoring 
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the peak heights of the three peptides assesses the saturation of the MS detector. The peak 
height of bradykinin increased linearly (R2 =0.999) from 1 nM to 100 nM. However, at 
concentrations of 1 and 10 µM, the peak height deviated from the linear behavior and 
plateaued. The peak height of the weakly retained thymopentin increased linearly (R2 
=0.999) between 1 nM and 100 nM. At 1 µM, the height began to deviate from linear and 
subsequently decreased. Comparatively, the peak height of the low abundant peptide A is 
linear (R2 = 0.998) for all four concentrations of sample detected. This indicates that the MS 
detector had been saturated for the highly abundant species.  
The values for peak area and height of the thymopentin suggest that volume 
overloading of the stationary phase is occurring. This is not surprising as the volume of 
sample is continually being introduced to the short bed (600 µm) for 5 minutes. In addition, 
the capacity of the bed for weakly retained analytes may decrease as the presence of other 
compounds with higher retention increases. Finally, to determine mass overload bradykinin 
and peptide A were compared. The peak area of bradykinin is linear through the first four 
orders of magnitude (R2 = 0.998), while there is a deviation from linear behavior at 10 µM. 
The peak area of peptide A is linear (R2 = 0.999) through the four concentrations that it was 
observed suggesting that the lower abundant analyte is still retained as the stationary phase 
has not yet been saturated. Based on these data, we conclude that the capacity of the 600 µm 
integrated SPE bed was sufficient to investigate samples that exist over a wide range of 
concentrations. The MS detector and the CE separation become saturated prior to saturation 
of the SPE bed. Even at a very large concentration of the four peptide mix, the peak height 
and area of the trace component A continued to increase linearly, indicating that the SPE bed 
still had capacity to hold more analyte. These conclusions are further supported by the 
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behavior of angiotensin II and met-enkephalin, two additional abundant and well-retained 
peptides, as well as peptide B, an additional trace component in the four peptide mixture 
(Figure 5.7).  
 
 
Figure 5.7. Peak area, peak width, and peak height for angiotensin II, met-enkephalin, and 
unidentified peptide B (Figure 5.3). The concentration of the sample loaded ranged from 1 nM to 10 
µM.  
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5.3.3 Complex Mixture Separations 
In order to investigate the performance of the microchip with integrated sample 
processing for complex mixtures, a Phosphorylase B (Phos B) tryptic digest was analyzed 
using both CE-ESI-MS/MS and SPE-tITP-CE-ESI-MS/MS. Peptide identification via 
tandem MS is necessary for many applications, such as protein mapping, proteomics, or 
hydrogen/deuterium exchange mass spectrometry. Therefore, tandem MS was used to 
demonstrate the compatibility of the SPE-tITP-CE-ESI method with MS/MS. The 
concentration of the sample for CE was 5 µM, while the concentration of the sample for 
SPE-tITP-CE was 50 nM. Figure 5.8 illustrates a comparison of the electropherograms for 
each separation. Both methods are contained on the same plot, with the CE electropherogram 
offset for visualization. The inset shows an expanded view of the CE electropherogram. Six 
peptides were selected and are labeled in each of the electropherograms for comparison. As 
illustrated by the figure, the BPI signal intensity for the SPE-tITP-CE electropherogram is 
more than an order of magnitude greater than the CE electropherogram, despite having a 
100-fold lower sample concentration. By comparing the average peak area of the six labeled 
peptides, enrichment factors of 270, 550, 541, 712, 426, and 418 were calculated (ignoring 
any electrokinetic bias) for peaks 1 through 6, respectively. Furthermore, the appearance of 
each electropherogram is very similar. For the CE separation, the average (n=3) peak 
capacity was 128, with a median 4σ peak width of 1.68 seconds and a separation window of 
214.8 seconds. For the SPE-tITP-CE separation, the average (n=3) peak capacity was 147, 
with a median 4σ peak width of 1.267 seconds, a separation window of 186.4 seconds.  
It is well known that SPE is biased towards analytes that are retained well on the 
chromatographic material, and that the method is less effective at analyzing species that are 
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poorly retained. For reversed-phase SPE, analytes that are very polar are typically not 
retained, resulting in a loss of these analytes.45 In order to determine if a similar number of 
peptides were observed between the CE-MS and SPE-tITP-CE-MS Phos B samples, the 
electropherograms were analyzed using the software Biopharmalynx. For the CE-MS 
analysis, the average (n=3) number of peptides observed in the Phos B digest was 151. 
Comparatively, the average (n=3) number of peptides observed for the SPE-tITP-CE-MS 
method was 97, which corresponds to a 35 % decrease. While completely eliminating the 
bias of SPE towards well retained analytes is challenging, reducing the number of peptides 
lost could be accomplished by further optimizing the stationary phase, such as selecting a 
more retentive reversed-phase material or selecting a mixed mode stationary phase, such as 
combining reversed-phase retention with ion exchange retention.46,47    
! 140!
 
Figure 5.8 Electropherograms of Phosphorylase B tryptic digests separated using CE-ESI (5 µM) and 
SPE-tITP-CE-ESI (50 nM). The CE-ESI electropherogram has been offset for visualization. The inset 
shows an expanded view of the CE-ESI electropherogram. 
Figure 5.9 illustrates the separation of 0.5 mg/mL E. Coli tryptic digest using the 
integrated microchip. The separation run time is just under 10 minutes long. The calculated 
peak capacity for the separation was 241.5, with a median 4σ peak width of 1.85 s, a 
separation window of 447.6 s, and 155 peaks counted. Busnel et al. coupled tITP-CE with a 
porous tip emitter to perform a similar separation of 0.5 mg/mL E. Coli tryptic digest.48 The 
authors reported an observed peak capacity (4σ peak width) of 192 in 80 min. The metric of 
! 141!
peak capacity/min can be used to compare the rate at which different separations techniques 
can generate resolving power. The separation described in the Busnel manuscript has a peak 
capacity/min of 2.4 based on the reported peak capacity and a separation run time of 80 min. 
The calculated value for the electropherogram in Figure 5.9 corresponds to a peak 
capacity/min of 24.1, based on a peak capacity of 241.5 and a run time of 10 min. If you 
include the 5 minutes of loading prior to the separation, the value of peak capacity/minute 
drops to 16.1, which is still over 6 times faster than the work reported by Busnel et al. 
Further optimization of the loading step prior to the separation will likely reduce the total 
analysis time of an individual sample.  
 
Figure 5.9. Electropherogram of SPE-tITP-CE-ESI separation of 0.5 mg/mL E. Coli digest.  
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5.4 Conclusion 
In conclusion, CE-ESI microchips were coupled with on-chip SPE beds to perform 
integrated sample processing. The separation of a four peptide mix was used to compare the 
sample processing and separation performance of CE-MS, SPE-CE-MS, and SPE-tITP-CE-
MS. Integrating SPE with CE-ESI microchips resulted in high pre-concentration values; 
however, the separation performance was significantly diminished. Introducing tITP focusing 
in between the SPE bed and the CE separation resulted in improved separation performance 
while maintaining high enrichment factors. The migration time and peak area reproducibility 
of the SPE-CE microchips was found to be similar to the microchips without integrated 
sample processing. The integrated microchips were utilized to investigate the separation of a 
Phosphorylase B, which resulted in a significant sensitivity increase while improving 
observed peak capacity. An E. Coli tryptic digest was analyzed, resulting in a much faster 
separation with higher peak capacity than previous reports of CE-MS in the literature. Future 
work will characterize the desalting capabilities of this design as well as investigating the use 
of alternate stationary phases for targeted analyses, such as ion-exchange or affinity capture. 
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CHAPTER 6: CONCLUSIONS AND FUTURE WORK 
6.1 Multi-dimensional Separations 
6.1.1. Summary 
We have described a multi-dimensional separations platform by coupling commercial 
liquid chromatography (LC) with microchip capillary electrophoresis – electrospray 
ionization (CE-ESI).1 In the second dimension, CE separations were performed every 10 
seconds and a peak capacity of 10 was observed, with a MS acquisition rate of 10 Hz. 
Separating a complex mixture of protein tryptic digests with the LC-CE system resulted in a 
total peak capacity of 1400 in 50 minutes. However, undersampling was a concern in both 
the CE dimension (MS data points per CE peak) and the LC dimension (CE separations per 
LC peak). Unfortunately, when performing those experiments, we were limited by the mass 
spectrometer acquisition rate, and could not improve sampling in either dimension without 
significantly decreasing the observed sensitivity. Following the initial demonstration of the 
hybrid LC-CE setup, we were able to modify a Waters Synapt G2 mass spectrometer, and 
increase the MS acquisition rate to 50 Hz. With the new acquisition rate, we were able to 
alleviate the undersampling concerns in both dimensions. CE separations were performed 
every 4 seconds, and the peak capacity observed was maintained at 10. At 50 Hz, each CE 
peak had 11 MS data points per peak. With CE injections every 4 seconds, each LC peak had 
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at least 3 CE injections per peak on average, which satisfies the minimum number required to 
maintain resolution in the first dimension.2 
6.1.2 Increasing MS Acquisition Rate 
Although we were able to increase the acquisition rate of the Waters Synapt G2, the 
mass spectrometer performance still limited the overall performance of the system. In the 
future, coupling the hybrid LC-CE-ESI setup with improved MS instrumentation capable of 
faster MS data acquisition without sensitivity loss could result in shorter analysis times, 
improved peak capacity, analyte identification via tandem MS (MS/MS), or potentially the 
simultaneous combination of all three improvements listed. Capillary electrophoresis is a 
very fast technique, and improvements to the speed and peak capacity could be realized if the 
MS acquisition rate were not a limiting factor. In 2003, McClain et al. described a microchip 
device coupling on-chip cell lysis with a CE separation and optical detection.3 For 4 cytosolic 
dyes released from lysed cells, a CE separation was observed that provided baseline 
resolution of all 4 dyes in just 2.2 seconds. The resulting peak capacity was 21.2, with a 
median peak 4σ width of 105 ms. This represents a CE separation that is half the duration of 
that utilized in the most recent LC-CE system, and provided more than twice the peak 
capacity. In order to achieve 10 MS data points per peak for a 105 ms 4σ peak width, a 
sampling rate of 95 Hz would be required. In 2014, Guetschow et al. described a sub-s 
electrophoretic separation for screening enzyme modulators.4 In 1998, Jacobson et al. 
demonstrated a sub-ms separation of two fluorescent dyes, indicating the high speed that CE 
is capable of realizing.5  
Aside from increasing the available peak capacity in the CE dimension, increasing the 
MS acquisition rate can potentially increase the CE separation speed. Reducing the CE 
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separation window would result in increased sampling of the LC dimension peaks, or permit 
the coupling of the CE microchip with LC separations with narrower peaks. This could result 
in a shorter overall analysis times by coupling with shorter LC separations, or improving the 
peak capacity of the system by reducing the LC peak width for the same separation time. 
According to the literature, a peak capacity of 200 should be achievable for a UPLC 
separation with a 10 min gradient.6,7 This corresponds to an average 4σ peak width of 3 
seconds in the LC dimension. As stated earlier, to maintain the resolution of the first 
dimension in a multi-dimensional separation, the first dimension must be sampled at least 3 
times.2 This would require a CE separation with a window of 1 second, which is 4x faster 
than what we have previously demonstrated. 
Finally, increasing the MS acquisition rate is necessary in order to couple the hybrid 
LC-CE-ESI system with tandem MS. MS/MS is an important tool for many different 
applications, such as proteomics, metabolomics, neonatal screening, and sports drug testing.8-
11 One method for performing data-independent MS/MS is Waters MSE, where high and low 
collision energy spectra are collected simultaneously by alternating between the two.12 As 
every other MS data point is either a high or low collision energy spectrum, the sampling rate 
in both the high-energy and low-energy scan is effectively cut in half. If MSE had been 
performed on the most recent LC-CE separation, it would have dropped the average number 
of MS data points per CE peak from the reported 11 to 5.5, below the threshold necessary to 
properly characterize the peak. 
Previously, a former graduate student in the Ramsey Lab, Dr. Nick Batz, investigated 
high speed separations using CE-ESI microchips.13 Figure 6.1 illustrates electropherograms 
for a 4-peptide mix separated on a CE-ESI microchip with a 3 cm long separation channel. 
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Two different field strengths were used, 500 V/cm (A) and 1500 V/cm (B). As illustrated by 
the figure, at 500 V/cm, the separation window is roughly 3.5 seconds in duration. At 1500 
V/cm, the separation window decreases to 1.1 seconds in duration. However, at the higher 
field strength, tailing is observed for the later migrating peaks, and the signal intensity has 
decreased approximately 3-fold. This illustrates that our CE-ESI microchips are capable of 
performing very fast separations, but that further optimization is required. 
 
Figure 6.1 Base peak index electropherogram for the high-speed CE-ESI-MS separation of a mixture 
containing fluorescein, methionine enkephalin, angiotensin II, bradykinin and thymopentin (listed 
from shortest to longest migration time). Data were obtained using a 3 cm device at an electric field 
strength of A) 500 V/cm and B) 1,500 V/cm. Figures and data courtesy of Dr. Nick Batz. 
 
6.1.3 Alternate Chromatography Modes 
 We demonstrated the hybrid LC-CE-ESI platform using a reversed-phase LC column 
for the analysis of peptides. One of the benefits of the hybrid LC-CE platform, as opposed to 
a monolithic integration of the LC column,14 is that the system can easily be coupled with 
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many different types of LC columns. The hybrid LC-CE-ESI setup uses commercial LC 
columns, so replacing the LC column with alternate stationary phases should be feasible with 
only minor modifications to the microchip. For example, by utilizing a reversed-phase LC 
column with superficially porous particles and large pore sizes, the system could be tuned 
towards the analysis of large molecules, such as intact proteins or antibodies.15,16 
Furthermore, a HILIC (Hydrophilic Interaction Chromatography) LC column could be 
utilized for the analysis of very polar compounds, such as metabolites.17 The mobile phase in 
HILIC separations are typically high organic, such as 60 – 95% acetonitrile, which should be 
compatible with the CE-ESI microchips.18 
6.2 Microchip CE-ESI for Hydrogen/Deuterium Exchange 
6.2.1 Summary 
 Hydrogen/deuterium exchange mass spectrometry is a powerful technique for 
analyzing protein structure. The technique has many advantages over conventional methods, 
such as low sample volume requirements, the ability to analyze proteins that will not 
crystalize, and the ability to probe analytes on a wide time scale.19 The current paradigm for 
HX MS utilizes fast LC separations at low temperatures in order to minimize deuterium back 
exchange and maintain the structural information.20 However, due to resistance to mass 
transfer, the separation performance of LC under these conditions is limited. On the other 
hand, capillary electrophoresis presents a promising separations platform for HX MS due to 
its inherent speed and separation performance. Furthermore, as opposed to LC, the efficiency 
of a CE separation should improve slightly at low temperature.21 We demonstrated the 
potential utility of microchip CE-ESI for HX MS. A CE separation of a pepsin digest of 
bovine hemoglobin resulted in a peak capacity of 62 with a separation time less than 1 
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minute, compared to a 4 minute UPLC separation with a peak capacity of 31. For a 
deuterium labeling experiment of bovine hemoglobin, a 2.5 min CE method performed at 
room temperature produced similar amounts of deuterium uptake and retention to an 8.5 min 
LC method performed at 0 °C. However, a much larger initial concentration of the protein 
stock was required for the CE method due to decreased sensitivity. Furthermore, the 
sequence coverage of the CE method was much lower than that observed for the LC method. 
For the CE method, the observed sequence coverage of the α and β chain was 48.2% and 
84.8%, respectively, while the observed sequence coverage for the LC method was 97.9% 
and 92.4%, respectively.  
6.2.2 Coupling with an Improved Mass Spectrometer 
 The decreased sequence coverage values for the CE method are likely the result of 
many factors, one of which is the limitations of the mass spectrometer. Performing very rapid 
separations while maintaining high separation performance necessitates very narrow peaks. 
For the bovine hemoglobin CE separation, the median 4σ peak width was 0.61 s. Based on 
the sampling rate of the mass spectrometer there were only 3.8 MS data points per CE peak 
on average. Coupling the microchip CE-ESI method with a mass spectrometer that is capable 
of fast acquisition rates without decreasing the sensitivity will eliminate the peak 
undersampling and potentially result in increase protein sequence coverage.      
6.2.3. Low Temperature Microchip CE-ESI 
 As discussed in Chapter 4, we have investigated the performance of low temperature 
microchip CE-ESI. A proof of principle experiment indicated that lowering the temperature 
of a CE separation improved deuterium retention for a fully deuterated peptide (Figure 4.8) 
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Demonstrating the utility of the low temperature CE setup towards a HX MS labeling 
experiment should be quite feasible. As described previously, lowering the temperature of a 
CE separation increased the separation run time due to an increase in viscosity. However, it 
was demonstrated that increasing the field strength resulted in a faster separation with 
improved efficiency. Therefore, coupling the low temperature CE setup with HX MS 
analysis should be possible without increasing the total analysis time as long as a sufficiently 
high voltage can be applied to the microchip.   
6.2.4. Integrated Sample Processing 
 Microfluidic platforms are well suited towards integrating multiple components and 
functionalities onto a single device.14,22,23 For HX MS applications, integrating sample 
processing upstream of the CE separation will result in many advantages. First, integrating 
pre-concentration of the peptides prior to the separation will improve the sensitivity of the 
CE method. As discussed earlier, the sensitivity of the CE method was a limiting factor, both 
in terms of the initial protein concentration and the observed sequence coverage. Integrated 
pre-concentration will improve both of these outcomes.  
Second, integrated sample cleanup could improve the compatibility of the microchip 
CE-ESI method with additives for the protein digestion, such as denaturants and reducing 
agents. For example, current HX MS digestion protocols require high concentrations (0.5 to 4 
M) of guanidine hydrochloride to denature the protein and tris(2-carboxyethyl)phosphine to 
reduce disulfide bonds during the digestion.24 Integrated sample cleanup could result in a 
more direct translation of existing HX MS protocols to the microchip CE-ESI method. 
Furthermore, the inclusion of these additives should result in a faster and more complete 
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digestion, potentially reducing total experiment time and resulting in improved deuterium 
retention and protein sequence coverage. In Chapter 5, a method for integrating SPE with 
microchip CE-ESI was described. This method has potential for use in HX MS applications, 
but further optimization is required in terms of total experiment time, protein sequence 
coverage, and the ability to cleanup high concentrations of salts, denaturants, and reducing 
agents.  
Finally, the inclusion of integrated protein labeling and digestion on-chip prior to 
sample processing and separation could result in a fully automated platform for HX MS 
analysis. Various methods for on-chip protein digestion have been described in the 
literature.25-27 By placing the entire sample processing protocol on-chip, the total experiment 
time could be reduced, therefore lowering deuterium back exchange. Additionally, the 
required sample volume could be reduced by generating the sample on-chip, which could 
expand HX MS analysis to sample limited applications.   
6.3 Low Temperature Microchip CE-ESI 
6.3.1 Summary 
 A method for investigating low temperature microchip CE-ESI was described. A 4-
peptide mixture was separated at a constant electric field strength at temperatures ranging 
from 30 °C to 0 °C. The migration time of the analytes increased with decreasing 
temperature due to an increase in viscosity and changes to the BGE pH. As the temperature 
was lowered, the observed signal intensity also decreased, due to a decrease in the volumetric 
flowrate. The observed efficiency of the separations increased linearly as the temperature 
was lowered. The increase in separation efficiency was greater than that predicted by 
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theory,21 which was attributed to the attenuation of band broadening sources such as wall 
interactions or Taylor dispersion relative to diffusion. A separation of 4 peptides was 
compared at two different field strengths and temperatures to illustrate that increasing the 
field strength could offset the observed increase in migration time at lower temperatures. 
Furthermore, the efficiency of the separation increased as expected due to the increase in 
applied voltage. Finally, it was demonstrated that lowering the temperature of a CE 
separation could increase the observed deuterium retention. 
6.3.2 Optimization of ESI Performance 
 As discussed in Chapter 4, as the temperature of the CE separation was lowered, the 
observed signal intensity of the peaks also decreased. Lowering the temperature increases the 
solvent viscosity, which will decrease the volumetric flowrate. At high flowrates, ESI 
ionization is typically concentration sensitive; increasing the flowrate does not change the 
signal intensity. However, at lower flowrates, typically below 100 nL/min, ESI transitions to 
mass-sensitive, where changing the flowrate can change the sensitivity.28,29 Based on the 
observed flowrates, we would expect the signal intensity to decrease based on the decrease in 
flowrate (Figure 4.6). Furthermore, investigating the peak area of the 4 peptides as a function 
of temperature revealed that the peak area also decreased with temperature, as illustrated by 
Figure 4.7. However, no attempt was made to optimize the ESI in terms of position or emitter 
voltage, which will play a role in ESI sensitivity. Further investigation and optimization is 
required to maximize ESI sensitivity at lower temperatures.  
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6.3.3 Improving Migration Time RSD    
 For separations of a 4-peptide mix at constant field strength at different temperatures, 
the migration time RSD for the peptides was 1.5% or lower. While this value is small, 
previous reports indicate a much lower value for migration time RSD, typically 0.3%.1,30 The 
increased migration time RSD was attributed to variations in the temperature on the time 
scale of the separation. To perform low temperature CE separations, a Peltier thermoelectric 
device was controlled using a Wavelength Electronics temperature controlling unit. An 
aluminum water block was used as a heat sink for the Peltier. Based on the manufacturer’s 
specifications, the reproducibility of the temperature controlling unit should be on the order 
of 0.1%. An ice water bath in water circulator was used to provide water to the heat sink and 
to remove the buildup of heat from the Peltier. It was observed over the course of the 
experiment that the temperature of the water bath would change, and therefore the efficiency 
of heat removal would also change. This resulted in temperature fluctuations during the 
experiment. Replacing the water circulator and ice bath with an active cooling unit would 
likely eliminate these temperature fluctuations and improve the migration time RSD.  
6.3.4. Condensation 
 Lowering the temperature of the microchip may result in condensation occurring on 
the surface of the microchip. This buildup of moisture can lead to arcing between the applied 
voltage leads, and can be deleterious to separation performance. While the humidity of the 
environment was low enough during the course of the experiments for the low temperature 
CE work described in Chapter 4, we did investigate methods for controlling the humidity of 
surface of the microchip. One method was to enclose the microchip in an airtight container, 
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and replace the environment with a dry gas, such as compressed air or nitrogen. Figure 6.2 
depicts a photograph of the enclosed setup including the Peltier device, heat sink, and vias 
for the applied voltage leads.  
      
Figure 6.2. Photograph depicting a humidity controlled system for performing low temperature 
microchip CE ESI. The white square corresponds to the Peltier device. Cable guides on the top of the 
enclosure provide access vias for applied voltage leads.   
 Preliminary experiments indicated that this method worked to alleviate humidity 
concerns with low temperature CE. However, this method would not be compatible with HX 
MS analysis. As designed, the time between loading the microchip with sample, assembling 
the box, replacing the atmosphere with dry gas, and performing the separation is excessively 
long. This additional experimental analysis time would increase the window for deuterium 
back exchange and reduce the utility of the method for HX MS. Further methods for 
controlling the humidity around the surface of the microchip will require investigation and 
optimization. One method could be to cover the surface of the microchip with an insulating 
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material, such as rubber. This would reduce the exposure of the microchip surface with the 
atmosphere, and potentially reduce the instances of arcing. Another strategy could be to 
maintain the previous design for enclosing the microchip, but design an automated method 
for introducing sample to the microchip that does not require the filling and flushing of 
solvent reservoirs.    
6.4 Integrated Sample Processing 
6.4.1 Summary 
 CE is a technique that has many advantages, such as high speed, separation 
performance, and a wide analysis scope. On the other hand, CE often suffers from poor 
concentration sensitivity and a low tolerance for matrix components, which typically 
necessitates sample processing prior to separation and detection. Unfortunately, compared to 
LC, CE lacks a robust method for integrated sample processing. Chapter 5 described a 
method for integrating SPE with microchip CE-ESI. Enrichment factors for a mix of 4 
peptides ranged from approximately 70 to 799. However, coupling the SPE with the 
microchip CE-ESI drastically reduced the separation performance. Incorporating a tITP 
focusing step following the transfer of analyte from the SPE bed to the CE separation 
resulted in improved separation performance while maintaining the pre-concentration factors. 
The SPE-tITP-CE-ESI method was utilized to analyze a phosphorylase B trypic digest. 
Compared to a CE-ESI separation, the observed signal intensity was increased by more than 
an order of magnitude, and the peak capacity improved to 147 from 128. Compared to a 
tITP-CE-MS analysis of the mixture, the number of peptides observed decreased by roughly 
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30%. Finally, the method was applied to an E. Coli tryptic digest, resulting in a peak capacity 
of 240 in a 10 min separation.  
6.4.2 Alternate Stationary Phases 
 Much like the LC-CE-ESI platform described in Chapter 2, the SPE-CE-ESI 
microchip should be amenable for a wide variety of stationary phases. Changing the 
stationary phase will result in a method that can target many different analytes and can be 
tuned for many different applications. Unlike the LC-CE platform, the loading solvent or 
mobile phase does not enter the CE separation channel; many more options for stationary 
phase chemistries will be compatible with the separation and detection. For example, TiO2 
particles have been demonstrated to selectively isolate phosphopeptides.31  Lectins are 
commonly used for the extraction of glycopeptides from complex mixtures.32 
Immunoaffinity sorbents have been described in the literature for the selective capture of 
dozens of separate analytes.33 Further investigation and optimization will be required in order 
to ensure the pre-concentration methods are compatible with the microchip. Overall, we view 
this microchip as a very broad platform that can target many different applications with only 
minor modifications to the design and operating procedure.  
6.4.3 Increasing Bed Capacity 
 As discussed in Chapter 5, the sequence coverage for a protein digest sample 
decreased when analyzed by SPE-tITP-CE-ESI. Increasing the volume of the bed could 
potentially increase the loading capacity of the microchip and improve the observed sequence 
coverage and peptide count values. The current dimensions of the bed are roughly 10 µm 
deep, 70 µm wide, and 600 µm long, for a total bed volume of approximately 425 pL. One 
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method for increasing the volume of the SPE bed would be to increase the length and width. 
To a point, this strategy would likely work to increase the volume and capacity of the bed. 
However, a bed that was too long and/or wide could impart broadening on the analyte band 
and ultimately reduce the separation efficiency of the method. Further investigation will be 
required in order to determine at what point this occurs. If a higher capacity bed is required 
beyond what could be accomplished by increasing the length and width, the SPE bed could 
also be fabricated to be deeper. This may have other advantages as well, by increasing the 
compatibility of the chip with alternate stationary phases. For example, we currently have 
TiO2 particles in lab that could potentially be used with the microchip. However, the 
diameter of the particles is 20 µm, necessitating a chip that is at least 20 µm deep. Many 
other stationary phases that could be coupled with this microchip design could also be greater 
than 10 µm in diameter.  
Two options exist for increasing the depth of the SPE bed: increasing the depth of the 
entire microchip or decoupling the depth of the SPE bed from the CE separation channel. 
Both options have their own advantages and disadvantages. Decoupling the depth of the SPE 
bed from the CE channel results in more complex fabrication procedures. Previous 
investigations of this approach revealed that protecting the CE separation channel during the 
etching process to achieve a deeper SPE bed was challenging. It was observed that the 
resulting CE separation channel depth was irregular, which could have deleterious affects on 
the separation performance. Additionally, transitioning from a deep SPE bed to a shallower 
region on the chip can introduce broadening of the analyte band prior to the separation. Some 
amount of broadening can be tolerated due to the tITP focusing; however, the extent of 
acceptable broadening will require further investigation. Increasing the depth of the whole 
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microchip is a much simpler strategy, but concerns exist about the separation performance 
due to the racetrack effect. The racetrack effect describes a phenomenon where broadening is 
imparted onto an analyte band as it passes through a turn.34,35 For the analyte, the inside path 
is shorter than the outside path; additionally, the field strength is higher on the inside of the 
turn, both of which result in band dispersion.  
The strategy to minimize dispersion in turns is to use an asymmetrical, tapered turn 
shape, and keep the radius of the turns as low as possible.35 Fabrication of the microchips 
utilizes isotropic wet etching; therefore, the channels become wider as they become deeper.36 
Based on our fabrication techniques, the channel width of a turn for a chip that is 10 µm deep 
is around 25 µm. If the depth were increased to 20 µm, the channel width increases to 45 µm. 
To investigate the performance of the CE-ESI microchip with deeper channels, a microchip 
etched to 10 µm deep was compared to a similar design that was etched 20 µm deep. The 
length of the separation channel was 23 cm in both cases. Based on the report by Griffiths et 
al, the width of the channel in the turn should be 1/3 of the width of the linear channels.35 
Therefore, because the widths of the channels in the turn were approximately 50 µm, the 
widths of the standard channels were fabricated to be 150 µm wide. Figure 6.5 illustrates 
electropherograms for a mixture of 4 peptides in addition to the neutral marker fluorescein. 
The same BGE and similar field strengths were used for both separations. For the 10 µm 
deep microchip, the average efficiency of the 4 peptides was calculated to be 485,000 
theoretical plates at 395 V/cm. For the 20 µm deep microchip, the average efficiency was 
343,000 theoretical plates at 420 V/cm, which corresponds to approximately a 30% decrease 
in separation performance. 
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Figure 6.5. Electropherograms for the separation of a 4 peptide mix plus the neutral marker 
fluorescein. The figure on the left depicts a microchip that is etched to 10 µm deep, while the figure 
on the right corresponds to a microchip that is etched 20 µm deep.      
 As demonstrated by the figure, etching the microchip deeper and increasing the 
widths of the turns resulted in a decrease of the observed separation performance. Further 
investigation of the microchip design would be required in order to optimize the separation 
performance of microchips etched deeper than 10 µm. One method for improving the 
separation performance of deeper microchips could be to increase the turn radius.34 As the 
turn radius increases, so does the time required for the analyte to travel through the turn. If 
the time required to transverse the turn is high compared to the time for the analyte to diffuse 
across the width of the turn, the affect of the different migration times will be minimized. 
However, a larger turn radius increases the footprint of the device, and a compromise 
between device depth, performance, and footprint will need to be reached.          
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6.4.4 Sample Cleanup Optimization  
 It was previously demonstrated that the SPE-tITP-CE microchip could function with 
100 mM NaCl contained in the sample. A phosphorylase B digest was separated with and 
without the 100 mM NaCl. The separation performance was similar for each sample. 
Comparing the sequence coverage between the two digests revealed a decrease for the 
sample that contained the NaCl, from 70.9% to 62.5%. This is likely due to the washing step 
that occurred after loading the sample on the bed and prior to elution. Further optimization is 
required to minimize analyte loss during the washing step and also probe the limit of the 
sample cleanup capability of this design. Increasing the size of the SPE bed will likely reduce 
the observed analyte loss. Furthermore, many applications contain a high concentration of 
matrix additives in the sample that must be cleaned up prior to separation. For example, 
protein digestions often require high concentrations of salts, reducing agents and denaturants, 
such as urea and iodoacetomide.37 Additionally, the detection of metabolites in biological 
fluids such as serum or urine requires sample processing prior to analysis.38,39 CE-MS has 
also been demonstrated for environmental and food safety analysis, which presents unique 
challenges associated with sample cleanup.40-42 The ability of the SPE-tITP-CE microchips to 
cleanup these matrices require further investigation. 
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